JP2015518862A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015518862A5 JP2015518862A5 JP2015513962A JP2015513962A JP2015518862A5 JP 2015518862 A5 JP2015518862 A5 JP 2015518862A5 JP 2015513962 A JP2015513962 A JP 2015513962A JP 2015513962 A JP2015513962 A JP 2015513962A JP 2015518862 A5 JP2015518862 A5 JP 2015518862A5
- Authority
- JP
- Japan
- Prior art keywords
- curcumin
- complex
- phospholipid
- oil
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ZIUSSTSXXLLKKK-HWUZOJPISA-N Curcumin Natural products C1=C(O)C(OC)=CC(\C=C\C(\O)=C/C(=O)/C=C/C=2C=C(OC)C(O)=CC=2)=C1 ZIUSSTSXXLLKKK-HWUZOJPISA-N 0.000 claims description 289
- 229940109262 Curcumin Drugs 0.000 claims description 144
- 235000012754 curcumin Nutrition 0.000 claims description 144
- 239000004148 curcumin Substances 0.000 claims description 144
- 150000003904 phospholipids Chemical class 0.000 claims description 91
- 239000000203 mixture Substances 0.000 claims description 69
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 39
- 229940067606 Lecithin Drugs 0.000 claims description 39
- 239000000787 lecithin Substances 0.000 claims description 39
- 235000010445 lecithin Nutrition 0.000 claims description 39
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 26
- 239000002904 solvent Substances 0.000 claims description 26
- MXXWOMGUGJBKIW-YPCIICBESA-N Piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 13
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 9
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims description 8
- 229960001285 Quercetin Drugs 0.000 claims description 8
- 235000005875 quercetin Nutrition 0.000 claims description 8
- 229930002344 quercetin Natural products 0.000 claims description 8
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 7
- 235000019100 piperine Nutrition 0.000 claims description 7
- 229940075559 piperine Drugs 0.000 claims description 7
- 239000002671 adjuvant Substances 0.000 claims description 6
- 230000000240 adjuvant Effects 0.000 claims description 6
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 claims 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims 2
- 239000003921 oil Substances 0.000 description 85
- 235000019198 oils Nutrition 0.000 description 85
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 60
- 229940067631 Phospholipids Drugs 0.000 description 42
- 239000000243 solution Substances 0.000 description 34
- MBMBGCFOFBJSGT-KUBAVDMBSA-N Docosahexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 24
- 235000014113 dietary fatty acids Nutrition 0.000 description 24
- 239000000194 fatty acid Substances 0.000 description 24
- 150000004665 fatty acids Chemical class 0.000 description 24
- 229960004363 doconexent Drugs 0.000 description 23
- 229940090949 docosahexaenoic acid Drugs 0.000 description 23
- 238000009835 boiling Methods 0.000 description 18
- 241000237536 Mytilus edulis Species 0.000 description 15
- 230000001965 increased Effects 0.000 description 15
- 235000020638 mussel Nutrition 0.000 description 15
- 239000003085 diluting agent Substances 0.000 description 13
- 238000001704 evaporation Methods 0.000 description 13
- 238000010992 reflux Methods 0.000 description 10
- 230000001225 therapeutic Effects 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 9
- 239000012530 fluid Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 8
- 238000005538 encapsulation Methods 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 230000002195 synergetic Effects 0.000 description 8
- 201000011510 cancer Diseases 0.000 description 7
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 7
- 230000036912 Bioavailability Effects 0.000 description 6
- OYHQOLUKZRVURQ-IXWMQOLASA-N Linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 6
- 229940012843 Omega-3 Fatty Acids Drugs 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 238000007792 addition Methods 0.000 description 6
- 230000035514 bioavailability Effects 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 239000006014 omega-3 oil Substances 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical group O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 238000005755 formation reaction Methods 0.000 description 4
- 201000010238 heart disease Diseases 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N n-butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 150000003905 phosphatidylinositols Chemical class 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229940106134 krill oil Drugs 0.000 description 3
- 230000000670 limiting Effects 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000006011 modification reaction Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000003586 protic polar solvent Substances 0.000 description 3
- 229940119224 salmon oil Drugs 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 2
- 241000238366 Cephalopoda Species 0.000 description 2
- 229960001231 Choline Drugs 0.000 description 2
- 206010011401 Crohn's disease Diseases 0.000 description 2
- 241000238424 Crustacea Species 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N Curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 206010012601 Diabetes mellitus Diseases 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- UNJJBGNPUUVVFQ-ZJUUUORDSA-N Phosphatidylserine Chemical compound CCCC(=O)O[C@H](COC(=O)CC)COP(O)(=O)OC[C@H](N)C(O)=O UNJJBGNPUUVVFQ-ZJUUUORDSA-N 0.000 description 2
- 229940083466 Soybean Lecithin Drugs 0.000 description 2
- 229940005741 Sunflower lecithin Drugs 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- PREBVFJICNPEKM-YDWXAUTNSA-N bisdemethoxycurcumin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)CC(=O)\C=C\C1=CC=C(O)C=C1 PREBVFJICNPEKM-YDWXAUTNSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- CRBHXDCYXIISFC-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CC[O-] CRBHXDCYXIISFC-UHFFFAOYSA-N 0.000 description 2
- 238000010668 complexation reaction Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- HJTVQHVGMGKONQ-LUZURFALSA-N demethoxycurcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=CC(O)=CC=2)=C1 HJTVQHVGMGKONQ-LUZURFALSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drugs Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 238000011068 load Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000005445 natural product Substances 0.000 description 2
- 230000000926 neurological Effects 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229940060184 oil ingredients Drugs 0.000 description 2
- 150000008103 phosphatidic acids Chemical class 0.000 description 2
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 2
- 150000003907 phosphatidylinositol monophosphates Chemical class 0.000 description 2
- -1 phosphatidylinositol triphosphate Chemical class 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000008347 soybean phospholipid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- ODXAYQMCAAQOSY-UHFFFAOYSA-O 2-[hydroxy-[3-hydroxy-2-(octadecanoylamino)octadec-4-enoxy]phosphoryl]oxyethylazanium Chemical compound CCCCCCCCCCCCCCCCCC(=O)NC(COP(O)(=O)OCC[NH3+])C(O)C=CCCCCCCCCCCCCC ODXAYQMCAAQOSY-UHFFFAOYSA-O 0.000 description 1
- 206010059512 Apoptosis Diseases 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 230000036826 Excretion Effects 0.000 description 1
- 230000036740 Metabolism Effects 0.000 description 1
- VODZWWMEJITOND-OWWNRXNESA-N N-Stearoylsphingosine Chemical compound CCCCCCCCCCCCCCCCCC(=O)NC(CO)C(O)\C=C\CCCCCCCCCCCCC VODZWWMEJITOND-OWWNRXNESA-N 0.000 description 1
- LKQLRGMMMAHREN-YJFXYUILSA-N N-stearoylsphingosine-1-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)[C@H](O)\C=C\CCCCCCCCCCCCC LKQLRGMMMAHREN-YJFXYUILSA-N 0.000 description 1
- 101700032731 PIP2 Proteins 0.000 description 1
- 208000008443 Pancreatic Carcinoma Diseases 0.000 description 1
- YHHSONZFOIEMCP-UHFFFAOYSA-O Phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 description 1
- 101700083883 UBA2 Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000001772 anti-angiogenic Effects 0.000 description 1
- 230000003110 anti-inflammatory Effects 0.000 description 1
- 230000001028 anti-proliferant Effects 0.000 description 1
- 230000003078 antioxidant Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 230000001684 chronic Effects 0.000 description 1
- 231100000762 chronic effect Toxicity 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement Effects 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 235000019503 curry powder Nutrition 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 230000004059 degradation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000002349 favourable Effects 0.000 description 1
- 239000008079 hexane Substances 0.000 description 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 description 1
- 230000002209 hydrophobic Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000035786 metabolism Effects 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 229930014626 natural products Natural products 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 230000000275 pharmacokinetic Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229950004354 phosphorylcholine Drugs 0.000 description 1
- 150000003019 phosphosphingolipids Chemical class 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000002829 reduced Effects 0.000 description 1
- 230000003252 repetitive Effects 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Images
Description
æ¬çºæã¯ãã¯ã«ã¯ãã³ã®ãã€ãªã¢ãã€ã©ããªãã£ã«ããããããã³ããã«é¢ããæ¹åãããã³ã¯ã«ã¯ãã³ã®ãã€ãªã¢ãã€ã©ããªãã£ãæ¹åããè€åäœããã³çµæç©ãäœè£œããæ¹æ³ã«é¢ããã
ã¯ã«ã¯ãã³ã¯ãã¹ãã€ã¹ã¿ãŒã¡ãªãã¯äžã«ååšããååç©ã§ãããã¯ã«ã¯ãã³ã¯ãå€ãã®ç 究ã«ãããŠãæé
žåãæççæ§ãæå¢æ®æ§ããã³æè¡ç®¡åœ¢æ掻æ§ãªã©ã®è¬çåŠçå¹æãæããããšã瀺ãããŠããããã®ãããªãã®ãšããŠãã¯ã«ã¯ãã³ã¯ãçãå¿çŸæ£ãç³å°¿ç
ãã¯ããŒã³ç
ããã³æ§ã
ãªç¥çµæ§çŸæ£ãªã©ã®çŸæ£ã«å¯ŸåŠããããã®æšçã«çžåœããããã®ãããéå»ïŒïŒããïŒïŒå¹Žéã«ãããã¯ã«ã¯ãã³ã«å¯Ÿããæ矩深ãç 究ããã£ãã
ã¯ã«ã¯ãã³ã®éèŠãªé·æã¯ãã«ã¬ãŒãªã©ã®é£ç©äžã®ã¹ãã€ã¹ãšããŠæ°äžçŽã«ããã䜿çšãããŠãã倩ç¶ååç©ã§ãããããã«å¹
åºãåãå
¥ããããŠããããšã§ããããããªãé·æã¯ãé«çšéã§ãã£ãŠãå¯äœçšãã»ãŒãªãããšã§ããããŸããããã¯ã調éè²»çšãæ¯èŒçäœãã宀枩ã§è¯å¥œã«ä¿åãããã
ãããã®é·æã«ããããããããŸã åãçµãã¹ãæéèŠèª²é¡ã¯ãåç©ã«ãããŠãã€ãªã¢ãã€ã©ããªãã£ãäœããšããã¯ã«ã¯ãã³ã®åšç¥ã®åé¡ã§ãããããã¯ã溶解床ã«ä¹ãããããã«åžåæ§ã«ä¹ããã身äœããæåºããããã³ïŒãŸãã¯è¿
éã«ä»£è¬ãããããšãå«ãèŠå ã®çµã¿åããã®ããã§ãããšèããããã
éå»ã«ã¯ããã®äœæº¶è§£æ§ãå°ãªããšãã€ã³ãããå®éšã«ãããŠå
æãããããããã¯ãã¯ã«ã¯ãã³ã®æº¶è§£æ§åäžãä¿é²ããïŒïŒ³ïŒ¯ãŸãã¯ïŒŽïœïœ
ïœ
ïœ ïŒïŒãªã©ã®æ
äœãæ·»å ããããšã«ãããããããäž»ã«ïŒ€ïŒïŒ³ïŒ¯ãªã©ã®æ
äœã¯ãå³ãäžå¿«ãªãã®ãšãã補é è²»çšããã³å·¥çšãä»å ããã¯ã«ã¯ãã³ãïŒæ¶è²»è
ã奜ãïŒå€©ç¶ç£ç©ã§ãããšããé·æãæãªãã®ã§ãæ²»çè¬ã«ããããããã®æ
äœã®æ·»å ã¯é©åãªéçã§ã¯ãªãã
ã¯ã«ã¯ãã³ãšæ²¹ãçµã¿åãããããšã«ãã£ãŠãã¯ã«ã¯ãã³ã®å
šèº«ç³»ãžã®åã蟌ã¿ãæ¹åããåŸããããããã¯ã«ã¯ãã³ã¯æ²¹ãšçµåããªãã®ã§ãæ··ååŸã«çž£æ¿æ¶²ããè±èœãããã¯ã«ã¯ãã³ããã³æ²¹ã®æ··åç©ãæ¿ããæ¹æããããšã«ãããããäžéšãå¯æº¶åããããããå
ãã«æ¹åããçæç©ãæäŸããåŸããããããã¯ã«ã¯ãã³ãæéçµéãšãšãã«æ²éããã®ã§ä¿åå¯èœæéã¯éå®ããããã¯ã«ã¯ãã³ããã³æ²¹ã®æ··åç©ãããã«æ¿ããæ··åãããã«ããããããçæç©ãé å¿ããããšã«ãããã¯ã«ã¯ãã³ããã³æ²¹ã®æ®ã©ãå¹ççã«åé¢ãããã
åžåïŒå®å®æ§ãä¹ãããšããåé¡ãå
æããã¯ã«ã¯ãã³ã®æçãªå¹æãæ倧åããããšãéå»æ°å幎ã«ãããå€ãã®ã¢ãããŒããç 究ãããŠããããããã«ã¯ããªããœãŒã æ§ãŸãã¯ãªã³è質æ§é ãããç²åããã³æ§é é¡äŒŒäœã®èª¿è£œãå«ãŸãããïœïœïœïœããïŒïœïœïŒïŒ°ïœïœïœïœïœïœïœ
ïœïœïœïœïœïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒâïŒïŒïŒã¯ããããã®æ§ã
ãªã¢ãããŒãã®åªããæŠèª¬ãæäŸããã
äŸãã°ãïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒã¯ãæ€ç©ãŸãã¯åæèµ·æºã®è質ãçšããã¯ã«ã¯ãã³ãšã®ãªã³è質è€åäœãèšèŒãããã¯ã«ã¯ãã³ãšè質ãšã®ã¢ã«æ¯ãé«ãå ŽåãåŸãããè€åäœäžã§ã¯ã«ã¯ãã³ãçŽïŒïŒïŒïŒïŒ
ãšãªã£ããããããåŸãããçæç©ã¯ãç²æ§ã®ããããç¶ç©è³ªã§ãã£ãããã®ãããã«ãã»ã«åããã®ã¯å®è³ªçã«äžå¯èœãšãªããããã«ããã®çæç©ã¯æ®ã©ç¢ºå®ã«é å€åœ¢æ
ã§æäŸããããé å€ã¯ã補é ã®èŠ³ç¹ããè€åäœã®ééã«é©åãªåœ¢æ
ã§ãããã®ã®ãã«ãã»ã«åã¯ãç¹ã«æ²¹æ§ã®åŠæ¹ç©ã«å¯ŸããŠããé
åçãªéžæè¢ã§ããåŸããã«ãã»ã«åã容æã«éæå¯èœã§ããã®ã¯ãåŸãããè€åäœæº¶æ¶²ã®ç²æ§ãé«ãããªãå Žåã®ã¿ã§ããããšãå€ãã
å€ãã®ç 究ã°ã«ãŒããæ¢çŽ¢ããŠããç°ãªãæ段ã¯ãã¯ã«ã¯ãã³ãã¢ãžã¥ãã³ããšåãããããšã§ããããããªã³ãã±ã«ã»ãã³ãŸãã¯ãªã¡ã¬âïŒããªäžé£œåèèªé
žãäŸãã°ãã³ãµãããµãšã³é
žïŒïŒ€ïŒšïŒ¡ïŒããã³ïŒãŸãã¯ãšã€ã¹ã³ãµãã³ã¿ãšã³é
žïŒïœ
ïœïœïœïœïœïœïœïœ
ïœïœïœïœ
ïœïœïœïœ ïœïœïœïœïŒïŒïŒ¥ïŒ°ïŒ¡ïŒãªã©ã®ãããªååç©ã¯ãæè¿ãã¯ã«ã¯ãã³ãšçµã¿åãããŠäœ¿çšãããå Žåãçžä¹çãªæ²»çå¹æãçããããããšã瀺ãããããæ£ç¢ºãªäœçšæ©æ§ã¯ãŸã äžæã§ããããããã®ã¢ãããŒãã¯ïŒ¡ïœïœïœïœããïŒïŒïŒïŒã§ãæŠèª¬ãããŠããã
ã¯ã«ã¯ãã³ã®çžä¹äœçšã¯ãããã³ïŒ¥ïŒ°ïŒ¡ãå«ãããªäžé£œåèèªé
žã®æ¯èŒçå°ãããµãã»ããïŒçŽïŒïŒã«éå®ããããšãèããããŠããããããã¯ããããã®èèªé
žã®ççŽ éé·ãïŒïŒä»¥äžã§ããããã§ãããããã«ããã身äœããããã容æã«åžåã§ããããã«ãªããããã¯ãïŒïŒã®ççŽ éé·ãæãããªããŒã«é
žãªã©ã®ä»ã®èèªé
žãšåçã§ããã
äŸãã°ãïœïœïœ
ïœïœïœïœïœããïŒïŒ£ ïœïœïœïœ
ïœ ïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒã¯ãå€æ°ã®ä¹³ç现èæ ªã®é»å®³ã«ãããããã³ã¯ã«ã¯ãã³ã®çžä¹äœçšãèšèŒãããããã§ãé»å®³ãããŠããä¹³ç现èæ ªã®ã¿ã€ãã«äŸåããŠããšã¯ã«ã¯ãã³ãšã®æé©æ¯ããããïŒïŒïŒããïŒïŒïŒã§ãã£ãããšãå ±åãããã
ãããªãç 究ã«ãããŠãïœïœïœïœããïœïœïœïœïœïœïœïœ ïœïœïœ ïœïœïœïœ
ïœ ïŒïŒïŒïŒïŒïŒïŒïŒïŒ³ïŒïŒïŒïŒâïŒïŒã¯ãçŽïŒïŒïŒïŒïŒïŒïŒ€ïŒšïŒ¡å¯Ÿã¯ã«ã¯ãã³ïŒã®æ¯ã§ãèµèç现èã®äžåœ¢æ
ã§ããïœïŒ°ïŒ£âïŒçŽ°èã«ãããã¢ãããŒã·ã¹ã«å¯ŸããŠæ倧å¹æã瀺ãããããšãå ±åããã
åŸã£ãŠãã¯ã«ã¯ãã³ãšã¢ãžã¥ãã³ããäŸãã°ïŒ€ïŒšïŒ¡ãªã©ãšã®æé©æ¯ã«å¯ŸããŠåŠæ¹è
ã«æéãäžããçè«çãªæ
å ±ããããã®ã®ãïŒææãããç確ãªæ²»çå¹æã«äŸåããŠç°ãªãåŸãïŒææã®æ¯ãä¿æããåæã«ã¯ã«ã¯ãã³ã®äžå®å®æ§ãäžæº¶æ§ããã³ä¹åžåæ§ããªãã³ã«å¥œãŸããç²åºŠã®èŠä»¶ãªã©ãçµæç©ã®ä»ã®èŠå ã®åšèŸºã®åé¡ã«ã察å¿ããããšããçµæç©ãåŠæ¹ããããšã¯å°é£ã§ããåŸãããšãå€ãã
äŸãã°ããšã¯ã«ã¯ãã³ãšã®éã®ææã®ã¢ã«æ¯ïŒããã³æ¿åºŠïŒãéæããããšããè©Šã¿ã«ãããŠãããã«ããç²åºŠãããé«ããªãåŸãåæ§ã«è£œé ã«å¯ŸããŠã«ãã»ã«åãéžæããããšãå°é£ãšãªãåŸãã
åŸã£ãŠãããäžå®ã®é·æã«ãããããããã¯ã«ã¯ãã³ã®ãã€ãªã¢ãã€ã©ããªãã£ããã³æ²»çå¹æãã¯ã«ã¯ãã³ã®è² è·éåäžèœãåŸãããçµæç©ã®å®å®æ§ãªãã³ã«å¥œéœåãªå€åœ¢ã§è¬å€ã補é ãã簡䟿æ§ïŒè²»çšã«ã€ããŠæ¹åããããšãäŸç¶ãšããŠéåžžã«å¿
èŠãšãããŠããã
æ¬çºæã®ç®çã¯ãåè¿°ã®åé¡ã®ïŒä»¥äžã«å¯ŸåŠããããšããŸãã¯å°ãªããšãå
¬è¡ã«æçšãªéžæè¢ãæäŸããããšã§ããã
æ¬æ现æžäžã§åŒçšããããããç¹èš±ãŸãã¯ç¹èš±åºé¡ãå«ããåèæç®ã¯å
šãŠãåç
§ã«ããæ¬æ现æžã«ãã£ãŠçµã¿èŸŒãŸãããäœããã®åèæç®ãå
è¡æè¡ãæ§æããããšãåãå
¥ãããã®ã§ã¯ãªããåèæç®ã®è«èã¯ãããã®èè
ã䞻匵ããããšãè¿°ã¹ãåºé¡è
ã¯ãåŒçšããæžé¡ã®æ£ç¢ºæ§ããã³é©åæ§ã«ç矩ãå±ããæš©å©ãä¿æãããå€ãã®å
è¡æè¡åè¡ç©ãæ¬æ现æžäžã«å¯ŸããŠåç
§ããããã®ã®ããã®åèæç®ããã£ãŠããããã®æžé¡ã®äœãããããã¥ãŒãžãŒã©ã³ãã«ãããããŸãã¯äœããã®ä»ã®åœã«ãããåœæè¡åéã§ã®å
±éã®äžè¬çç¥èã®äžéšã圢æããããšã«ã¯ãªããªãããšãæããã«ç解ããããã
æ¬æ现æžãéããŠããå«ãïŒïœïœïœïœïœïœïœïœ
ïŒããšããèªãŸãã¯ãã®å€åœ¢ç©ãäŸãã°ãå«ãïŒïœïœïœïœïœïœïœïœ
ïœïŒããŸãã¯ãå«ãïŒïœïœïœïœïœïœïœïœïœïœïŒããªã©ã¯ãè¿°ã¹ãããèŠçŽ ãæŽæ°ãããã¯æ®µéãŸãã¯èŠçŽ æŽæ°ãããã¯æ®µéã®çŸ€ãå«ãããšãæå³ãããã®ã§ãããããããä»ã®èŠçŽ ãæŽæ°ãããã¯æ®µéãŸãã¯èŠçŽ ãæŽæ°ãããã¯æ®µéã®çŸ€ã®æé€ãæå³ãããã®ã§ã¯ãªãããšãç解ããããã
æ¬çºæã®ãããªãæ
æ§ããã³é·æã¯ãåãªãäŸãšããŠäžãããã次ã®èšèŒããæããã«ãªããã
æ¬çºæã®ç¬¬äžã®æ
æ§ã«ãããšããªã³è質ããã³ã¯ã«ã¯ãã³ãå«ãè€åäœã§ãã£ãŠããªã³è質ãæµ·ç£ç©æ²¹ç±æ¥ã§ããããšãç¹åŸŽãšããè€åäœãæäŸãããã
æ¬çºæã®ãããªãæ
æ§ã«ãããšããªã³è質ããã³ã¯ã«ã¯ãã³ãå«ãè€åäœã§ãã£ãŠããªã³è質ãæµ·ç£ç©æ²¹ããã³ã¬ã·ãã³ç±æ¥ã§ããããšãç¹åŸŽãšããè€åäœãæäŸãããã
æ¬çºæã®ãããªãæ
æ§ã«ãããšããªã³è質ããã³ã¯ã«ã¯ãã³ã䌎ãè€åäœãå«ãçµæç©ã§ãã£ãŠãè€åäœäžã®ãªã³è質ãæµ·ç£ç©æ²¹ç±æ¥ã§ããããšãç¹åŸŽãšããçµæç©ãæäŸãããã
æ¬çºæã®ãããªãæ
æ§ã«ãããšãå®è³ªçã«æ¬æ现æžäžã®äžèšã®ãããªè€åäœãŸãã¯çµæç©ã調補ããæ¹æ³ã§ãã£ãŠã
ïœïŒæº¶åªäžã§ããéã®ã¯ã«ã¯ãã³ã溶解ãããããšã«ãã£ãŠç¬¬äžã®æº¶æ¶²ãçæããïŒ
ïœïŒæµ·ç£ç©æ²¹ç±æ¥ã®ããéã®ãªã³è質ãšç¬¬äžã®æº¶æ¶²ãæ··åããããšã«ãã£ãŠãããªã溶液ãçæããïŒ
ïœïŒè€åäœãçæãããããã«ããã®ãããªã溶液ãåŠçãïŒ
ïœïŒæº¶åªããè€åäœãåé¢ããã
段éãå«ããæ¹æ³ãæäŸããã
ïœïŒæº¶åªäžã§ããéã®ã¯ã«ã¯ãã³ã溶解ãããããšã«ãã£ãŠç¬¬äžã®æº¶æ¶²ãçæããïŒ
ïœïŒæµ·ç£ç©æ²¹ç±æ¥ã®ããéã®ãªã³è質ãšç¬¬äžã®æº¶æ¶²ãæ··åããããšã«ãã£ãŠãããªã溶液ãçæããïŒ
ïœïŒè€åäœãçæãããããã«ããã®ãããªã溶液ãåŠçãïŒ
ïœïŒæº¶åªããè€åäœãåé¢ããã
段éãå«ããæ¹æ³ãæäŸããã
æ¬çºæã®ãããªãæ
æ§ã«ãããšãå®è³ªçã«æ¬æ现æžäžã®äžèšã®ãããªçµæç©ãçšããåŠçœ®ã®æ¹æ³ãæäŸããããã®çµæç©ã¯ã次ã®ç¶æ
ã®ãã¡ïŒã€ã«å¯ŸããŠãåŠçœ®ãããã¯äºé²ãè¡ãããã«ããŸãã¯å°ãªããšãè£å®åŠçœ®ãŸãã¯äºé²ãæäŸããããã«äœ¿çšãããïŒ
ã»çã
ã»å¿çŸæ£ã
ã»ç³å°¿ç ã
ã»ã¯ããŒã³ç ããã³
ã»æ§ã ãªç¥çµæ§çŸæ£ã
ã»çã
ã»å¿çŸæ£ã
ã»ç³å°¿ç ã
ã»ã¯ããŒã³ç ããã³
ã»æ§ã ãªç¥çµæ§çŸæ£ã
æ¬çºæã¯ãé©ãã¹ãããšã«ãããã³æå©ã«ããªã³è質å«éãé«ããããã³ïŒ¥ïŒ°ïŒ¡ãªã©ã®ããªäžé£œåèèªé
žã«å€©ç¶ã«å¯ãæµ·ç£ç©æ²¹ç±æ¥ã®ãªã³è質ã®å·§åŠãªäœ¿çšã®æ©æµãåãããç°¡æœã«ã¯ãæ¬çºæã¯ã
âæµ·ç£ç©æ²¹ç±æ¥ã®ãªã³è質ãçšããŠå®å®ãªè€åäœã®åœ¢æãå¯èœã«ããå®å®ãªè€åäœã圢æãããããšã«ãã£ãŠæåã®åé¢ãé»æ¢ãïŒåŸã£ãŠãæ¬çºæã¯ã¯ã«ã¯ãã³ã®å¹æçãªåžåã確å®ã«ãããïŒã
âé«ã¬ãã«ã®ãªã³è質ããã³ãåæ§ã«é«ã¬ãã«ã®ããªäžé£œåèèªé žãäŸãã°ïŒ€ïŒšïŒ¡ããã³ïŒ¥ïŒ°ïŒ¡ãªã©ãæäŸããïŒæµ·ç£ç©æ²¹ãªã³è質ã®å°Ÿéšã«ãããŠã®ããã«æ¬è³ªçã«ååšãããïŒãããã¯ãèèªé žã¬ãã«ãåäžãããåŸã£ãŠã¯ã«ã¯ãã³ãšèèªé žãšã®ææã®ã¢ã«æ¯ã®éæãä¿ããåæ§ã«ããã¯ããããã®èèªé žãšã¯ã«ã¯ãã³ãšã®éã§èŠãããçžä¹çå¹æãæäŸããããã«æçã§ããã
âæµ·ç£ç©æ²¹ç±æ¥ã®ãªã³è質ãçšããŠå®å®ãªè€åäœã®åœ¢æãå¯èœã«ããå®å®ãªè€åäœã圢æãããããšã«ãã£ãŠæåã®åé¢ãé»æ¢ãïŒåŸã£ãŠãæ¬çºæã¯ã¯ã«ã¯ãã³ã®å¹æçãªåžåã確å®ã«ãããïŒã
âé«ã¬ãã«ã®ãªã³è質ããã³ãåæ§ã«é«ã¬ãã«ã®ããªäžé£œåèèªé žãäŸãã°ïŒ€ïŒšïŒ¡ããã³ïŒ¥ïŒ°ïŒ¡ãªã©ãæäŸããïŒæµ·ç£ç©æ²¹ãªã³è質ã®å°Ÿéšã«ãããŠã®ããã«æ¬è³ªçã«ååšãããïŒãããã¯ãèèªé žã¬ãã«ãåäžãããåŸã£ãŠã¯ã«ã¯ãã³ãšèèªé žãšã®ææã®ã¢ã«æ¯ã®éæãä¿ããåæ§ã«ããã¯ããããã®èèªé žãšã¯ã«ã¯ãã³ãšã®éã§èŠãããçžä¹çå¹æãæäŸããããã«æçã§ããã
ãã®æ现æžãéããŠãæµ·ç£ç©æ²¹ãšããçšèªã¯ãéé¡ããã³ç²æ®»é¡ãªã©ã®æµ·ç£çç©ç±æ¥ã®äœããã®æ²¹ãæå³ãããšè§£éãã¹ãã§ããããã®æ²¹ã¯ãããªäžé£œåèèªé
žã®å°ãªããšãïŒã€ã®ã¿ã€ããå«æãããªã³è質ïŒåæ°ãŸãã¯è€æ°ïŒãå«ãã
ãã®ãããªæµ·ç£ç©æ²¹ã®ããã€ãã®å
·äœäŸãšããŠã¯ãã€ã¬ã€æ²¹ããªãã¢ãæ²¹ããµãŒã¢ã³æ²¹ãã€ã«æ²¹ãªã©ãæãããããæµ·ç£ç©æ²¹ã®å¥ã®äŸã¯ãéåµãç¹°ãè¿ãã«ãªããããããéé¡ãŸãã¯ç²æ®»é¡ç±æ¥ã®æ²¹ã§ããåŸãã
äžèšã§äŸç€ºãããããããªã©ã®æµ·ç£ç©æ²¹ã¯ãæçã«ãæ¯èŒçé«ããªã³è質å«éãæãããåŸã£ãŠããããã¯ãæçã«ãäžèšã§ããã«è«ããããã«ãã¯ã«ã¯ãã³ãšãªã³è質ããã³èèªé
žãšã®å¥œãŸããã¢ã«æ¯ã®éæãä¿ãããã«æ¬çºæã«å¯ŸããŠäœ¿çšããåŸããäžèšã§äŸç€ºããããã®ãªã©ã®æµ·ç£ç©æ²¹ãçšããããšã«ãã£ãŠãæ¬è€åäœã¯ãŸããæçã«ãæµ·ç£ç©æ²¹ç±æ¥ã®è質äžã«ååšããã¯ã«ã¯ãã³ãšãšãã«ïŒ€ïŒšïŒ¡ãŸãã¯ïŒ¥ïŒ°ïŒ¡ãªã©ã®ãªã¡ã¬âïŒèèªé
žã«ãã£ãŠããããããçžä¹çæ²»çå¹æãæäŸããã
åœç¶ã®ããšãªãããæåã«ïŒäŸãã°ã¢ã»ãã³æ²æ®¿ã«ããïŒæµ·ç£ç©æ²¹ãããªã³è質ãæœåºãã次ãã§ç¶ããŠã¯ã«ã¯ãã³ã«æ·»å ããŠïŒæµ·ç£ç©æ²¹ã®æ®åæåãå·®ãåŒããïŒãè€åäœã圢æãããããšãå¯èœã§ããããã®ãããªå Žåã«ãããŠããªã³è質ã®æ²æ®¿åŸãããç¶ã®ç©è³ªãçãåŸã次ã«ãããåžéå€ã§èãåŸããã®åŸã¯ã«ã¯ãã³ãšè€åäœåãããã
奜ãŸããã¯ãæ¬çµæç©ã¯æµ·ç£ç©æ²¹ãå«ããããã¯ãæµ·ç£ç©æ²¹ã®æåã®å€ããã¯ã«ã¯ãã³ã®æ²»çæå¹æ§ãŸãã¯å®å®æ§ãæ¹åãåŸãå¯èœæ§ãããã®ã§ã奜ãŸããéžæè¢ã§ãããäŸãã°ãã€ã¬ã€æ²¹ã¯ãçŽïŒïŒçš®é¡ã®æ§ã
ãªã¿ã€ãã®èèªé
žãæããã
èèªé
žïŒ€ïŒšïŒ¡ããã³ïŒãŸãã¯ïŒ¥ïŒ°ïŒ¡ãšã¯ã«ã¯ãã³ãšã®éã®ãã®çžä¹äœçšãéåžžã«é·ãéç¥ãããŠããã«ãããããããç£æ¥çã§ã¯ãã¯ã«ã¯ãã³ãæµ·ç£ç©æ²¹èµ·æºã®ãªã³è質ãšå®éã«è€åäœåãããšããæ¬çºæã«è³ã£ãè
ã¯ããªãã£ããä»ãŸã§ãç 究è
ããæããã«ããã®ã¯ïŒ€ïŒšïŒ¡ïŒãªã¡ã¬ïŒãã¯ã«ã¯ãã³ãšçµã¿åãããããšã®ã¿ã§ããããããããã®ãããªæåã«å¯ããªã³è質ãšã¯ã«ã¯ãã³ãå®éã«è€åäœåãããããã«ãã£ãŠåäžæåã§ïŒã€ã®æçãªå¹æãéæããããšïŒããªãã¡ãèèªé
žã®éã®çžä¹äœçšããã³ãŸããªã³è質ãšã®è€åäœåœ¢æããå©çãåŸãããšïŒã¯èããŠããªãã£ãã
äžæ¹ã§ãç 究è
ãã¯ãæåã«ãã¯ã«ã¯ãã³ãè€åäœåããããã«ãã€ãºã¬ã·ãã³æ²¹ãªã©ã®æ€ç©æ²¹ã䜿çšããããšãæ€èšããããã€ãºãªã³è質ã¯ãããã«ãããŠéåžžã«ããåžåãããããšãç¥ãããŠãããé«æäžéã§ãã€ã³ããã§åç©ã«ãããŠæ
¢æ§å¹æãå
šã瀺ãããªãã®ã§ããã®ã¯ã«ã¯ãã³è€åäœåã®èŠãšãªããã®ã§ãã£ããšèããããããŸããããã¯ããã€ãºæ²¹ã«ååšãããªããŒã«é
žã®ãããªè±å¯ãªéã®ããªäžé£œåèèªé
žã«ãã£ãŠãå¿çŸæ£ã®ãããªçŸæ£ã®ãªã¹ã¯ãäœäžãããããã®é
åçãªéžæè¢ãšãªã£ããããã©ãã倧ããªæ¬ ç¹ã¯ãæ€ç©æ²¹äžã®ïŒãªããŒã«é
žé
žã®ãããªïŒçéã®èèªé
žããã³ã¯ã«ã¯ãã³ãšã®çžä¹äœçšãå ±åãããŠããªãããšã§ããã
æ¬æ现æžãéããŠããªã³è質ãšããçšèªã¯ãçæ°Žæ§ã®å°Ÿéšããã³èŠªæ°Žæ§ã®é éšãå«ãäœããã®ã¿ã€ãã®è質ãæå³ãããšè§£éãã¹ãã§ãããæ¬çºæã®æèã«ãããŠããªã³è質ã¯ãã¯ã«ã¯ãã³ãä¿è·ããããããã»ã«è€åäœã圢æãããããã«äœ¿çšãããã
奜ãŸããã¯ãæµ·ç£ç©æ²¹ã¯ãïŒïŒïŒ
ïœïŒïœãè¶
ãããªã³è質ãå«æããããµãŒã¢ã³æ²¹ãã€ã¬ã€æ²¹ããªãã¢ãæ²¹ããã³ã€ã«æ²¹ãªã©ã®æµ·ç£ç©æ²¹ã¯å
šãŠããªã³è質å«éãïŒïŒïŒ
ãäžåãããšãç¥ãããŠããããªã³è質ã¬ãã«ãé«ãããç¹ã«å¥œãŸããæµ·ç£ç©æ²¹ã¯ãçŽïŒïŒïŒ
ïœïŒïœãªã³è質ã¬ãã«ã§ããã€ã¬ã€æ²¹ã§ããã
æã奜ãŸããã¯ãæµ·ç£ç©æ²¹ã¯ããããïŒïŒïŒ
ïœïŒïœã®ãªã³è質ãå«æããã
ãã奜ãŸããã¯ããªã³è質ã¯ããã¹ãã¡ããžã«ã³ãªã³ïŒïŒ°ïŒ£ïŒããã¹ãã¡ããžã³é
žïŒïŒ°ïŒ¡ïŒããã¹ãã¡ããžã«ãšã¿ããŒã«ã¢ãã³ïŒïŒ°ïŒ¥ïŒããã¹ãã¡ããžã«ã»ãªã³ïŒïŒ°ïŒ³ïŒããã¹ãã¡ããžã«ã€ãã·ããŒã«ïŒïŒ°ïŒ©ïŒããã¹ãã¡ããžã«ã€ãã·ããŒã«ãªã³é
žïŒïŒ°ïŒ©ïŒ°ïŒããã¹ãã¡ããžã«ã€ãã·ããŒã«ïŒãªã³é
žïŒïŒ°ïŒ©ïŒ°ïŒïŒããã³ãã¹ãã¡ããžã«ã€ãã·ããŒã«ïŒãªã³é
žïŒïŒ°ïŒ©ïŒ°ïŒïŒãããªã矀ããéžæãããã
æã奜ãŸããã¯ãæ¬è€åäœäžã®ãªã³è質ã®å°ãªããšãäžéšã¯ãã¹ãã¡ããžã«ã³ãªã³ïŒïŒ°ïŒ£ïŒã§ãããããã¯ããäžè¬ã«äœ¿çšããããªã³è質ã§ãããç£æ¥çã§ããç解ãããŠããããã§ãããããããæœåšçã«ãªã³è質ã®äœããïŒã€ãŸãã¯çµã¿åãããæ¬çºæãšãšãã«äœ¿çšãåŸãã
ç¹°ãè¿ãã«ãªãããããã³ïŒ°ïŒ©ã®äž¡æ¹ãæããæµ·ç£ç©æ²¹ã®è¯å¥œãªäŸãšããŠã¯ãã€ã¬ã€æ²¹ããªãã¢ãæ²¹ããã³ãµãŒã¢ã³æ²¹ãæããããã
ãããã¯ããªã³è質ã¯ãå¹
åºãã¯ã©ã¹ã®ãã¹ãã¹ãã£ã³ãŽè質ããéžæãããã
ãã®ä»£æ¿çãªå®æœåœ¢æ
ã«ãããŠããªã³è質ã¯ãã»ã©ãããã¹ããªã«ã³ãªã³ãŸãã¯ã»ã©ãããã¹ããªã«ãšã¿ããŒã«ã¢ãã³ïŒãããããã¹ãã£ã³ãŽããšãªã³ããŸãã¯ïŒ£ïœ
ïœâïŒããã³ã»ã©ãããã¹ããªãªãããïŒïœïœïœïœïœïœïœïœïœïœïœïœïœïœïŒãããªã矀ããéžæãããã
æ¬æ现æžãéããŠãã¯ã«ã¯ãã³ãšããçšèªã¯ãäœããã®ã¯ã«ã¯ããã€ããæå³ãããã®ãšè§£éãã¹ãã§ãããã¯ã«ã¯ããã€ãã¯ãåçŽã«ãäžèšã®æ§é ã§ç€ºããããããªã¯ã«ã¯ãã³ã§ããåŸããããŸãã¯ååç©ã®å®å®æ§ãŸãã¯ä»ã®è¬ç©åæ
åŠçç¹æ§ãæ¹åããæ§ã
ãªååŠåºãæããã¯ã«ã¯ãã³ã®èªå°äœã§ããåŸãã
ã¯ã«ã¯ãã³ã¯ãã¿ãŒã¡ãªãã¯ãªã©ã®å€©ç¶æºããåé¢ããåŸããããŸãã¯äžé£ã®æè¡ãéããŠåæã«ãã調補ããåŸãã
æã奜ãŸããã¯ããã¡ããã·ã¯ã«ã¯ãã³ã䜿çšããããïœïœïœïœããïŒïŒ®ïœïœïŒïŒ°ïœïœïœïŒïŒïŒïŒïŒïŒïŒïŒ ïŒïŒïŒâïŒïŒïŒã«ãããŠããªã³è質åŠæ¹ç©ããã¯ã«ã¯ãã³ã®å Žåããããã¡ããã·ã«åã¯ã«ã¯ããã€ãã®åžåãé¡èã«åäžãããããšã瀺ãããåŸã£ãŠãæ¬çºæã§ã®äœ¿çšã«ç¹ã«é©çšå¯èœã§ãããäžè¬ã«äœ¿çšããããããªã代æ¿çã¯ã«ã¯ãã³ã¯ããã¹ãã¡ããã·ã¯ã«ã¯ãã³ã§ããã
ããããçŸåšå
¬ç¥ã§ããã«ãããŸãã¯å°æ¥éçºãããã«ãããã¯ã«ã¯ãã³ã®ããããä»ã®åœ¢æ
ãæ¬çºæã®ç¯å²ããéžè±ããããšãªãæ¬çºæã®äžéšãšããŠäœ¿çšãåŸãã
奜ãŸããã¯ãæ¬è€åäœã¯ïŒïŒ
ïœïŒïœãäžåãã¯ã«ã¯ãã³ãå«ãã
奜ãŸããã¯ãæ¬è€åäœã¯ãïŒããïŒïŒïŒ
ïœïŒïœã®éã®ã¯ã«ã¯ãã³ãå«ãã
æ¢ã«è«ããããã«ãããé«ãæ¿åºŠããã³è² è·éã®ã¯ã«ã¯ãã³ã¯ã身äœãžã®ã¯ã«ã¯ãã³ã®åžåãåäžããããšããæçµç®çãæ¹åããããã®ïŒã€ã®ã¹ãã©ããžãŒã§ããã
ãã奜ãŸããã¯ãæ¬è€åäœã¯ããããïŒããïŒïŒ
ïœïŒïœã®éã®ã¯ã«ã¯ãã³ãå«ããæ¬çºæã®è€åäœå
ã§ïŒïŒ
è¶
ã«ã¯ã«ã¯ãã³ã¬ãã«ãåäžãããããšã確ãã«å¯èœã§ãããããã¯ãæ¬æ现æžäžã§ããã«è«ããã
æ¬è€åäœäžã®ã¢ã«æ¯ã®å¥œãŸããäŸ
æã奜ãŸããã¯ãæ¬è€åäœäžã®ã¯ã«ã¯ãã³ãšããªäžé£œåèèªé žãšã®ã¢ã«æ¯ã¯ãçŽïŒïŒïŒããïŒïŒïŒïŒã®ç¯å²ã§ããã
æã奜ãŸããã¯ãæ¬è€åäœäžã®ã¯ã«ã¯ãã³ãšããªäžé£œåèèªé žãšã®ã¢ã«æ¯ã¯ãçŽïŒïŒïŒããïŒïŒïŒïŒã®ç¯å²ã§ããã
æã奜ãŸããã¯ãæ¬è€åäœäžã®ã¯ã«ã¯ãã³ãšããªäžé£œåèèªé
žãšã®ã¢ã«æ¯ã¯ãçŽïŒïŒïŒããïŒïŒïŒã®ç¯å²ã§ããã
ïœïœïœ
ïœïœïœïœïœããã³ïŒ³ïœïœïœïœãåç
§ããŠæ¢ã«è«ããããã«ãå®éšãè¡ãããç现èæ ªã«å¯ŸããŠæãæå¹ãªçžä¹äœçšãããããæã奜ãŸããã¢ã«æ¯ãçŽïŒïŒïŒå¯ŸïŒïŒïŒ€ïŒšïŒ¡å¯Ÿã¯ã«ã¯ãã³ïŒã§ãã£ãããšã瀺ãå ±åããããããããïŒïŒïŒïŒãäžåãããé«ãæ¯ïŒïŒ€ïŒšïŒ¡ããã³ïŒãŸãã¯ïŒ¥ïŒ°ïŒ¡ãªã©ã®ä»ã®èèªé
žå¯Ÿã¯ã«ã¯ãã³ïŒãçžä¹äœçšã瀺ãããšãæããã§ããããããã»ã©ã§ã¯ãªããç¹å®ã®æ²»ççšéïŒäŸãã°æšçãšããããšããç现èã®ã¿ã€ãïŒã«äŸåããŠãçžä¹äœçšãå¢åŒ·ããã¢ã«æ¯ãå€åãåŸãå¯èœæ§ã¯ååã«ããã
æã奜ãŸããã¯ãã¯ã«ã¯ãã³ãšæµ·ç£ç©æ²¹ç±æ¥ã®ãªã³è質ãšã®æ¯ã¯ããããïŒïŒïŒããïŒïŒïŒïŒã®éã§ããã
ãã®ãããªå¥œãŸããæ¯ã¯ãçºæè
ã«ããè¡ãããè©Šè¡äŸã§å¹æçã«äœçšããããšãåãã£ãŠãããã¯ã«ã¯ãã³ãšãªã³è質ãšã®é©åãªè€åäœåãããããããšããã瀺ãããŠããã®ã§æçã§ãããäŸãã°ãïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒã¯ãã¯ã«ã¯ãã³ãšãªã³è質ãšã®æ¯ãïŒïŒïŒãšããé«ããã®ã§ããå Žåãå®å®ãªè€åäœã«ãããŠæ倧ïŒïŒïŒ
ïœïŒïœã®ã¯ã«ã¯ãã³ãéæããåŸãããšãå®æœäŸïŒã§ç€ºãããšãæäŸãããæããã«ããªã³è質ã®éããã®æ¯ã§å¢å ãããå Žåãå®å®ãªè€åäœãéæãåŸãã
ã¯ã«ã¯ãã³ãšãªã³è質ãšã®ïŒïŒïŒïŒã®æ¯ãããã«ç¹ã«å¥œãŸãããã®äŸãäžèšã§æäŸããã
ã€ã¬ã€æ²¹ã¯ããããïŒïŒïŒ
ïœïŒïœãªã³è質ãæããçŽïŒïŒïŒ
ïœïŒïœïŒ¥ïŒ°ïŒ¡ããã³ïŒïŒïŒ
ãå«æããå
šéšã§çŽïŒïŒããïŒïŒïŒ
ã®ããªäžé£œåèèªé
žã§ããããã®å€§éšåããªã³è質ã«çµåãããåŸã£ãŠãïŒïœïœã®ã¯ã«ã¯ãã³ãïŒïŒïŒïœïœïŒãããïŒïŒïŒïŒ¬ïŒã®ã€ã¬ã€æ²¹ã«æ·»å ããããšã§ãã£ãå ŽåãåŸãããè€åäœã«ãããŠãããïŒïŒïŒïŒïŒã¯ã«ã¯ãã³å¯Ÿãªã³è質ïŒã®æ¯ãéæããåŸããã®è€åäœäžã§çŽïŒïŒïœïŒïŒ¬ïŒãŸãã¯ïŒïŒ
ïœïŒïœïŒã¯ã«ã¯ãã³ãæäŸãåŸãã
ç 究ãããïŒã€ã³ãããã§ã®è©Šè¡ã«ãã瀺åãããïŒèº«äœã«ãããã¯ã«ã¯ãã³ã®æ²»çå¹æã¯å
ãçŽïŒïŒÎŒïŒïŒïŒïœïœïŒïŒ¬ã¯ã«ã¯ãã³ïŒã§ããããšã瀺ããããåŸã£ãŠããã®çµæç©ã¯ã倧å¹
ã«éå°ãªã¯ã«ã¯ãã³ãæäŸãåŸããŸããã®å€§éšåãããã§ã«è«ãããããšããã€ã³ããã§åžåããåŸãªããããã¯ãçºæè
ãã«ããè¡ãããç 究ã«åºã¥ããæ·»å ãããã¯ã«ã¯ãã³ã®ïŒïŒïŒïŒ
è¿ãããªã³è質ãšè€åäœåå¯èœã§ããããšãæ³å®ããã
åæ§ã«ããã®äŸã¯ãçŽïŒïŒïŒïŒã®èèªé
žïŒããªãã¡ïŒ€ïŒšïŒ¡ããã³ïŒ¥ïŒ°ïŒ¡ãåããããã®ïŒãšã¯ã«ã¯ãã³ã®ã¢ã«æ¯ãæäŸããããšã¯ã«ã¯ãã³ãšã®å
·äœçãªã¢ã«æ¯ã¯ãçŽïŒïŒïŒã§ããããšã¯ã«ã¯ãã³ã®å Žåã¯ïŒïŒïŒã§ãããäžè¿°ã®ãšãããããã¯ãçžä¹çå¹æãããããããšã瀺ãããããšã¯ã«ã¯ãã³ãšã®ãäŸç€ºããã奜ãŸããã¢ã«æ¯å
ã§ãããããããäŸãã°ãæãæå¹ãªçžä¹å¹æãæããããšã瀺ããããçŽïŒïŒïŒïŒïŒ 察ã¯ã«ã¯ãã³ãžãšãããã®ã¢ã«æ¯ãåäžãããããšãäŸç¶ãšããŠå¥œãŸããã
äŸãã°ããã®æã奜ãŸããã¢ã«æ¯ã¯ãåçŽã«ãè€åäœäžã®ã¯ã«ã¯ãã³ã®éãçŽïŒïŒïŒ
ïœïŒïœã«å¢éããïŒããªãã¡ïŒ€ïŒšïŒ¡ã«å¯Ÿããæ¯ãïŒïŒïŒïŒïŒã«è¿ä»ãããïŒããšã«ãã£ãŠéæããåŸããããã¯ãå®å®ãªè€åäœãéæããã®ã«å¿
èŠãšãããïŒã€ã¬ã€æ²¹ã«ããæäŸãããïŒã¯ã«ã¯ãã³ãšãªã³è質ãšã®å¥œãŸããæ¯å
ã§ãåãäœå°ããããã®ã§éæå¯èœã§ããããããããã®ããã«è¡ãããšã«ãããŠãæ¬çµæç©ã¯ãã€ã¬ã€æ²¹ç±æ¥ã®ãªã³è質äžã®èèªé
žéãå€ãããã«éåžžã«ç²æ§ãŸãã¯ããç¶ã«ãªãåŸããããã¯æ²¹æ§ã®æ¶²äœãšãšãã«ã«ãã»ã«åœ¢æ
ã§æäŸããããšãå°é£ã§ããåŸãããããé«ãç²æ§ããã«ããªãããããé å€åœ¢æ
ã§æäŸãåŸãã
ã¬ã·ãã³ãå«ãè€åäœã®å¥œãŸããå®æœåœ¢æ
ã¯ã«ã¯ãã³ãšèèªé žãšã®ææã®ã¢ã«æ¯ã®éæããã³ãŸãã¯ç¶æãä¿ãããŸãèèªé žã«ããåŒãèµ·ãããåŸãç²æ§äžæã«äŒŽãåé¡ã®åé¿ãä¿ãããã«ãçºæè ãã¯ãç¹ã«å¥œãŸããç¬åµçãªæ§æ³ã«å°éãããããã¯ãè€åäœããã³ïŒãŸãã¯æ¬çºæã®è€åäœãå«æããç²æ§ãäœãæ²¹æ§æ¶²äœã®ã«ãã»ã«åã«å¯ŸããŠç¹ã«å¥œãŸããæ§æ³ã§ããã
ã¯ã«ã¯ãã³ãšèèªé žãšã®ææã®ã¢ã«æ¯ã®éæããã³ãŸãã¯ç¶æãä¿ãããŸãèèªé žã«ããåŒãèµ·ãããåŸãç²æ§äžæã«äŒŽãåé¡ã®åé¿ãä¿ãããã«ãçºæè ãã¯ãç¹ã«å¥œãŸããç¬åµçãªæ§æ³ã«å°éãããããã¯ãè€åäœããã³ïŒãŸãã¯æ¬çºæã®è€åäœãå«æããç²æ§ãäœãæ²¹æ§æ¶²äœã®ã«ãã»ã«åã«å¯ŸããŠç¹ã«å¥œãŸããæ§æ³ã§ããã
奜ãŸããã¯ãæ¬è€åäœã¯ãããéã®ã¬ã·ãã³ãå«ãã
æ¬æ现æžãéããŠãã¬ã·ãã³ãšããçšèªã¯ããªã³é
žãã³ãªã³ãèèªé
žãã°ãªã»ããŒã«ãç³è質ããã³ïŒãŸãã¯ããªã°ãªã»ãªããªã©ã®ä»ã®æåãšäžç·ã«ãªã³è質ãå«ãåç©ãŸãã¯æ€ç©çµç¹ç±æ¥ã®ç©è³ªã®äœããã®æ··åç©ãæå³ãããã®ãšè§£éãã¹ãã§ãããã¬ã·ãã³ãšããçšèªã¯ãåæ§ã«ãæ¬æ现æžãéããŠããããæ¬çºæã®æµ·ç£ç©æ²¹ãšã¯ç°ãªãç©è³ªã§ããããªã³è質æºãæäŸãããããã³ïŒ¥ïŒ°ïŒ¡ãªã©ã®ãªã¡ã¬âïŒèèªé
žãæ¬ ããŠãããã®ã§ãããšããããšãç解ãããã¹ãã§ããã
ãã®ãããªå®æœåœ¢æ
ã«ãããŠãåœç¶ã®ããšãªããããªã³è質ã®å
šäœéã¯åããŸãŸã§ããåŸïŒäŸãã°å¥œãŸããã¯ïŒïŒïŒïŒïŒããïŒïŒïŒã®éã®ã¯ã«ã¯ãã³å¯Ÿãªã³è質ïŒãäžæ¹ã§ã¬ã·ãã³ã¯ãã¯ã«ã¯ãã³ã«å¯Ÿãããã®å¥œãŸããæ¯ã«ã€ããŠãªã³è質ã®äžéšãæäŸããŠããã
çºæè
ãã¯ãã¬ã·ãã³ãçµã¿èŸŒãã éã«ã¯ã«ã¯ãã³ãšãªã³è質ãšã®ã¢ã«æ¯ãé床ã«å€åããªãã®ã§ããªã³è質ããã³ã¯ã«ã¯ãã³ãšã®æ¬è€åäœã®å®å®æ§ã劚ããããªãã£ãããšãèŠåºããã
åæ§ã«ãã¬ã·ãã³ããããã³æµ·ç£ç©æ²¹ãªã³è質ããã®ãªã³è質ã«ããç¶æãããè€åäœããã³çµæç©äžã§ã¯ã«ã¯ãã³ã®éãå¢éããåŸãã
çµæãšããŠãè€åäœäžã§èèªé
žéãå¢éãããªãã®ã§ãè€åäœå
ã§ã¯ã«ã¯ãã³ãšèèªé
žïŒæµ·ç£ç©æ²¹ãªã³è質ç±æ¥ïŒãšã®ã¢ã«æ¯ãåäžãããããšãã§ããããã«ãªããããã«ãããåŠæ¹è
ãã¯ã«ã¯ãã³ãšèèªé
žãšã®ã¢ã«æ¯ãåäžãããããšãã§ããããã«ãªãã ãã§ãªããèèªé
žã«èµ·å ããç²åºŠã®å¥œãŸãããªãäžæãåé¿ãããã
åŸã£ãŠãã¬ã·ãã³ãå«ãããšã«ãã£ãŠãå·§ã¿ã«ããããªããªã¡ã¬ïŒèèªé
žã®æ·»å ãšããæ¬ ç¹ïŒããªãã¡ç²åºŠäžæïŒãªããè€åäœã®å®å®æ§ããã³ã¯ã«ã¯ãã³ã®ä¿è·ã®ããã®æ¬ ãããšã®ã§ããªããªã³è質æºãäŸç¶ãšããŠæäŸããããããã«ãã¬ã·ãã³æ·»å ã«ãã£ãŠãè€åäœããã³ïŒãŸãã¯çµæç©ã®ç²æ§ã«é床ã«åœ±é¿ãäžããããšãªããã¯ã«ã¯ãã³ãšèèªé
žãšã®ã¢ã«æ¯ãææã®ã¬ãã«ãŸã§æå©ã«åäžãããããšãã§ããããã«ãªãã
奜ãŸããã¯ãæ¬çµæç©äžã®ã¬ã·ãã³ãšæµ·ç£ç©æ²¹ãšã®æ¯ã¯ïŒïŒïŒããïŒïŒïŒã®éã§ãããæã奜ãŸããã¯ãæ¬çµæç©äžã®ã¬ã·ãã³ãšæµ·ç£ç©æ²¹ãšã®æ¯ã¯ãããïŒïŒïŒã§ããã
奜ãŸããå®æœåœ¢æ
ã«ãããŠãã¬ã·ãã³ã¯æ€ç©ã¬ã·ãã³æ²¹ã§ãããäŸãã°ãæ€ç©ã¬ã·ãã³æ²¹ã¯ãçºæè
ãããæ¬çºæã«ç¹ã«é©çšã§ãããšèããããã€ãºã¬ã·ãã³æ²¹ãŸãã¯ããã¯ãªã¬ã·ãã³æ²¹ã§ããåŸããããã¯ãããã¯ãªã¬ã·ãã³æ²¹ããã³ãã€ãºã¬ã·ãã³æ²¹ã®äž¡æ¹ããè³æ©èœã«å¯Ÿããå¥åº·è£å©é£åãšããŠã³ãªã³ãæäŸããããã§ããã
ããããä»ã®ã¬ã·ãã³æºãæ¬çºæã®ç¯å²å
ã§ããã
çºæè
ãã¯ãç²æ§ãäžå©ã«ããã³äžå¿
èŠã«äžæããããšãåé¿ããããã«ãã¬ã·ãã³ããç²æ«åœ¢æ
ãšã¯å¥ç©ã§ããã液äœåœ¢æ
ã§æè¯ã«æäŸãããããšãäºèŠããã
奜ãŸããã¯ãæ¬çµæç©ã¯åžéå€ãå«ãã
çºæè
ãã¯ãïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒã§æããã«ãããããã«ãæµ·ç£ç©æ²¹ããã³ã¬ã·ãã³ã«ããæäŸããããªã³è質ã®éããã¯ã«ã¯ãã³æ¿åºŠãæ倧ïŒïŒ
ïœïŒïœãæœåšçã«ã¯ããé«ããã®ã§ãããå®å®ãªè€åäœãç¶æããã®ã«ååã§ããããšãäºèŠããããŸããçŽïŒïŒ
ïœïŒïœãäžåãããããã®ããé«ãã¯ã«ã¯ãã³æ¿åºŠã§ã¯ãæµ·ç£ç©æ²¹ãªã³è質ã®äžéšã®ä»£ããã«æ¬çµæç©ã«ã¬ã·ãã³ãæ·»å ãããŠããæ¬è€åäœã®ç²æ§ãã«ãã»ã«åã«ãšã£ãŠå®éçã§ãããã®ãè¶
ããŠäžæãåŸãã
奜ãŸããã¯ãæ¬çµæç©ã¯åžéå€ãå«ããããã¯ãã«ãã»ã«åã«å®éçãªã¬ãã«ã«ç²åºŠãç¶æããªãããããã³ã¯ã«ã¯ãã³ãšèèªé
žãšã®ææã®ã¢ã«æ¯ãæå©ã«éæããªãããæ¬è€åäœäžã®ã¯ã«ã¯ãã³æ¿åºŠãïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒã§è«ããããæ¿åºŠãžãšãã容æã«äžæããåŸããããã¬ã·ãã³æ·»å ãããç¹ã«å¥œéœåãªç¹æ§ã§ããããã®å·§åŠãªã¢ãããŒãã¯ãã¯ã«ã¯ãã³ãšãªã³è質ãšã®æ¯ãïŒïŒïŒãäžåããšããã«æŒãäžããããšãã§ããããã«ããªã³è質éãã€ã¬ã€æ²¹ãŸãã¯ã¬ã·ãã³ã®äœããã«ãã容æã«æäŸããåŸããšãããç¥èããã³çºæè
ã«ããè¡ãããäºåçãªè©Šéšã«äŸåãããåŸã£ãŠãããéã®ã¬ã·ãã³ïŒäŸãã°ïŒéšã®ã¬ã·ãã³ïŒãåžéå€ã§çœ®ãæããããšã«ãã£ãŠãæ¬çµæç©ã®å
šäœçãªç²æ§ãäœäžããåŸãããæ¬è€åäœã¯äŸç¶ãšããŠå®å®ãªãŸãŸã§ããåŸãã
äŸãã°ãïŒïŒïŒïŒïŒïŒåžéå€ïŒã¬ã·ãã³ïŒã€ã¬ã€æ²¹ïŒã®ããããã®æ¯ãçºæè
ã«ããäºæž¬ããããããããåœç¶ã®ããšãªãããåŠæ¹è
ãè€åäœäžã§ã¯ã«ã¯ãã³ãå®å®ã«ç¶æããéããåžéå€ãšã¬ã·ãã³ããã³ã€ã¬ã€æ²¹ãšã®ä»£æ¿çãªæ¯ãŸãã¯éã䜿çšãåŸããããã¯ãåçŽãªè©Šè¡ãéããŠå€å®ããããšã容æã§ãããåŸã£ãŠæ¬çºæã®ç¯å²ãè¶
ãããã®ãšã¿ãªãããã¹ããã®ã§ã¯ãªãã
奜ãŸããã¯ãåžéå€ã¯ãªã¬ã€ã³é
žã§ããããªã¬ã€ã³é
žãªã©ã®åžéå€ã®é·æã¯ãããããæ¬çµæç©ã®æ®äœãšããŠåãæ²¹æ§ããŒã¹ãæäŸããããæå©ã«ãªã³è質ãæ¬ ããåŸã£ãŠä»ã®æåã«å¯ŸããŠç²æ§ãäœããªãããšã§ãããåœç¶ã§ã¯ããããä»ã®ã¿ã€ãã®åžéå€ãå¯èœã§ããåŸãããçºæè
ãã¯ããªã¡ã¬ïŒã«å¯ããã®ã¯å¿çŸæ£ãšé¢é£ä»ããããŠããããããªã¡ã¬ïŒã«å¯ããã®ãå«ãŸãªããã®ã奜ãã
奜ãŸããã¯ãæ¬çµæç©ã®ç²åºŠã¯ãïŒïŒâã§ãïœïœïœïœïœïœ
ïŒïŒäžã§ïŒïŒïŒïœïœïœã§æž¬å®ããŠïŒïŒïŒïŒïœïŒ°ãäžåãã
奜ãŸããã¯ãæ¬çµæç©ã«ãããªãæåãçµã¿èŸŒãŸãåŸãããããã®æåã¯ãè€åäœã«å¿
ãããçµåããå¿
èŠã¯ãªãããå®å®æ§ã®åäžãä¿ãåŸããããŸãã¯äŸãã°æ¬çµæç©ã®æ²»çå¹æãåäžãããããã«ã¢ãžã¥ãã³ããšããŠæ·»å ããåŸãã
奜ãŸããã¯ãæ¬çµæç©ã¯ããªã¡ã¬ïŒèèªé
žã®ãããªãäŸçµŠæºãå«ããäŸãã°ãæ¬çµæç©ã«åå¥ã«ïŒ€ïŒšïŒ¡ãæ·»å ãåŸããçã®åŠçœ®ãŸãã¯äºé²ã«å¯Ÿããæ§ã
ãªç§åŠç 究ã«ãããŠãã¯ã¯ã«ã¯ãã³ãšãšãã«çžä¹çã«äœçšããããšã瀺ãããŠããããã®çžä¹äœçšãã¯ã«ã¯ãã³ã®ä»ã®æ²»ççšéã«å¯ŸããŠãæããã«ãªãå¯èœæ§ãããã
奜ãŸããã¯ãæ¬çµæç©ã¯ã±ã«ã»ãã³ãå«ãã
奜ãŸããã¯ãæ¬çµæç©ã¯ãããªã³ãå«ãã
ã±ã«ã»ãã³ããã³ãããªã³ã¯äž¡è
ãšããã¯ã«ã¯ãã³ã«å¯Ÿããã¢ãžã¥ãã³ãã§ããããšãäŸãã°æ²»çå¹ææ¹åã®ããã«ã¯ã«ã¯ãã³ã®åžåãŸãã¯å¹åãåäžãããããšãç¥ãããŠããã
奜ãŸããã¯ãã¢ãžã¥ãã³ãã®äžéšãŸãã¯å
šãŠããªã³è質ãšãšãã«åæã«è€åäœåããããäžèšã§è«ããããã«ãã±ã«ã»ãã³ããã³ãããªã³ã¯ã奜ãŸããã¯ã溶åªäžã§ã®æº¶è§£åã«ãããã³æµ·ç£ç©æ²¹ç±æ¥ã®ãªã³è質ïŒããã³ããã€ãã®å®æœåœ¢æ
ã«ãããŠå¥œãŸããã¯ã¬ã·ãã³ïŒåžéå€ïŒã®æ·»å åã«ãã¯ã«ã¯ãã³ãšäžç·ã«æ·»å ãããããã®ããã«ããŠãã±ã«ã»ãã³ã¯ãã¯ã«ã¯ãã³ãšåæ§ã«ããŠãªã³è質ãšè€åäœåã§ãããšèããããã
補é æ¹æ³
æ¬çºæã®ãããªãæ æ§ã«ãããšãå®è³ªçã«æ¬æ现æžäžã®äžèšã®ãããªçµæç©ã調補ããæ¹æ³ãæäŸãããæ¬æ¹æ³ã¯ã
ïœïŒç¬¬äžã®æº¶æ¶²ãçæãããããã«ã溶åªäžã§ããéã®ã¯ã«ã¯ãã³ã溶解ããïŒ
ïœïŒç¬¬äºã®æº¶æ¶²ãçæãããããã«ãæµ·ç£ç©æ²¹ç±æ¥ã®ããéã®ãªã³è質ãšç¬¬äžã®æº¶æ¶²ãæ··åãïŒ
ïœïŒè€åäœãçæãããããã«ã第äºã®æº¶æ¶²ãåŠçãïŒ
ïœïŒæº¶åªããè€åäœãåé¢ããã
段éãå«ãã
æ¬çºæã®ãããªãæ æ§ã«ãããšãå®è³ªçã«æ¬æ现æžäžã®äžèšã®ãããªçµæç©ã調補ããæ¹æ³ãæäŸãããæ¬æ¹æ³ã¯ã
ïœïŒç¬¬äžã®æº¶æ¶²ãçæãããããã«ã溶åªäžã§ããéã®ã¯ã«ã¯ãã³ã溶解ããïŒ
ïœïŒç¬¬äºã®æº¶æ¶²ãçæãããããã«ãæµ·ç£ç©æ²¹ç±æ¥ã®ããéã®ãªã³è質ãšç¬¬äžã®æº¶æ¶²ãæ··åãïŒ
ïœïŒè€åäœãçæãããããã«ã第äºã®æº¶æ¶²ãåŠçãïŒ
ïœïŒæº¶åªããè€åäœãåé¢ããã
段éãå«ãã
æ¬çºæã§äœ¿çšããã溶åªã¯ã䜿çšãããã¯ã«ã¯ãã³ã®ã¿ã€ããŸãã¯éãããã³çµæç©ãŸãã¯è€åäœã«å¯ŸããŠæå³ããããªã³è質ããã³ïŒãŸãã¯ä»ã®æåã®ã¿ã€ããŸãã¯éã«äŸåããŠå€åãåŸããåŸã£ãŠã溶åªã®æ£ç¢ºãªçµæã¯ãéå®ãããã®ãšã¿ãªãã¹ããã®ã§ã¯ãªãã
第äžã®æ§ææåã倩ç¶ã®æ€ç©ãŸãã¯åç©ã«åºã¥ãæœåºç©ã§ãã奜ãŸããå®æœåœ¢æ
ã¯ã次ã®ãªã¹ãããã®ïŒä»¥äžã®æº¶åªãå©çšãåŸãããããããåœç¶ã®ããšãšããŠããã®ãªã¹ãã¯ç¶²çŸ
çãªãã®ã§ã¯ãªããåŸã£ãŠãéå®ãããã®ãšã¿ãªãã¹ããã®ã§ã¯ãªãã
ã»ãããµã³
ã»ãã³ãŒã³
ã»ãã«ãšã³
ã»ãžãšãã«ãšãŒãã«
ã»ã¯ãããã«ã
ã»é ¢é ž
ã»ãã¿ããŒã«
ã»ã€ãœãããããŒã«
ã»ãããããŒã«
ã»ãšã¿ããŒã«
ã»ã¡ã¿ããŒã«
ã»ã®é ž
ã»ãžã¡ãã«ã¹ã«ããã·ãïŒ
ã»ã¢ã»ãã³ã
ã»ãããµã³
ã»ãã³ãŒã³
ã»ãã«ãšã³
ã»ãžãšãã«ãšãŒãã«
ã»ã¯ãããã«ã
ã»é ¢é ž
ã»ãã¿ããŒã«
ã»ã€ãœãããããŒã«
ã»ãããããŒã«
ã»ãšã¿ããŒã«
ã»ã¡ã¿ããŒã«
ã»ã®é ž
ã»ãžã¡ãã«ã¹ã«ããã·ãïŒ
ã»ã¢ã»ãã³ã
奜ãŸããã¯ã溶åªã¯ãããã³æ§æº¶åªã§ããããã®æ现æžãéããŠããããã³æ§æº¶åªãšããçšèªã¯ãé
žçŽ ã«çµåããŠããïŒããªãã¡ããããã·ã«åºïŒããŸãã¯çªçŽ ã«çµåããŠããïŒããªãã¡ã¢ãã³åºïŒæ°ŽçŽ ååãæããäœããã®æº¶åªãæå³ãããã®ãšè§£éãã¹ãã§ãããäžèšãªã¹ãããããããã³æ§æº¶åªãšããŠã¯ãé
¢é
žããã¿ããŒã«ãã€ãœãããããŒã«ããšã¿ããŒã«ãã¡ã¿ããŒã«ããã³ã®é
žãæããããã
æã奜ãŸããã¯ã溶åªã¯ãšã¿ããŒã«ã§ããã
奜ãŸããã¯ã段éïœïŒã¯ããããïŒïŒããïŒïŒéšäœç©ã®æº¶åªãçŽïŒéšã®ã¯ã«ã¯ãã³ã«æ··åããããšãå«ãã
ãã®æ¯ã«ãã£ãŠãã¯ã«ã¯ãã³ãé©åã«æº¶è§£ããæ··åéçšäžã®æ²æ®¿ãé»æ¢ããããšã確å®ã«ããããšãä¿ãããã®éçšã¯ãããé«æž©ã§æº¶è§£æ®µéãè¡ãããšã«ãã£ãŠãä¿é²ããåŸãã
ãšã¿ããŒã«ãªã©ã®æº¶åªã¯ãé£åã°ã¬ãŒãã®å質ã®ãšã¿ããŒã«ããããªã©ã®åŠçæè¡ã®ããã«åžè²©ãããŠããã®ã§æå©ã§ããåŸãã
å€ãã®æ¹æ³ãéããŠãè€åäœãçæãããããã«ã第äºã®æº¶æ¶²ãåŠçãã段éãéæãåŸãããªã³è質ããã³è¬ç©ãŸãã¯ååç©ãäŸãã°ïŒ·ïŒ¯ïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒã§å®èšŒãããŠãããã®ãªã©ãçšããŠããã»ã«è€åäœãçæãããããã®å€ãã®å
¬ç¥ã®æè¡ãããããŸãè€åäœã®çæãªãã§ã¯ãã¯ã«ã¯ãã³ããã³ãªã³è質ã¯äžå®å®ã§ãããæ¥éã«åé¢ãããããã¯ãä¿åå¯èœæéã®å®å®æ§ã«å¯Ÿããåé¡ã§ããã ãã§ãªããèæ¯æè¡ã§è¿°ã¹ãããããã«ãããã«ãã£ãŠã¯ã«ã¯ãã³ã®ãã€ãªã¢ãã€ã©ããªãã£ãäœäžãããåžåãæ¹åããããã«ãè€åäœã圢æããããšãå«ãæè¡ã«ãã£ãŠã身äœã§ã®åžåæ¹åã®ããã«ã¯ã«ã¯ãã³ã®ãªã³è質ãžã®çµåã®ç¶æãä¿ãã
奜ãŸããã¯ã段éïœïŒã¯ãèžçºã«ããåé¢ãå«ãã
奜ãŸããã¯ã段éïœïŒã¯ã溶åªã®æ²žç¹ãããé«ããã第äºã®æº¶æ¶²ã®æ®ãã®æåã®æ²žç¹ãããäœã枩床ãŸã§ç¬¬äºã®æº¶æ¶²ã®æž©åºŠãäžæãããããã«ç¬¬äºã®æº¶æ¶²ãå ç±ããããšãå«ãã
奜ãŸããã¯ã段éïœïŒã¯ãå§å容åšäžã§ç¬¬äºã®æº¶æ¶²ãå ç±ããããšãå«ãã
æã奜ãŸããã¯ã倧æ°å§ãäžåãæ°å§ã§ç¬¬äºã®æº¶æ¶²ãå ç±ãããããã«ããã溶åªããã³æµäœã®æ²žç¹ãäœäžããããäœã枩床ã§å¹ççã«èžçºãèµ·ããããã«ãªãã
ããã€ãã®å®æœåœ¢æ
ã«ãããŠã宀枩ã§æº¶åªã®èžçºãä¿é²ããããã«ãå§å容åšäžã®å§åãååã«äœäžããåŸãããã«ããå ç±ã®å¿
èŠæ§ããªããªãã
ããã€ãã®å®æœåœ¢æ
ã«ãããŠã溶åªããã³æµäœã®æ²žç¹ãäžæãããããã«ãå§å容åšäžã®å§åãäžæããåŸãããã«ããã溶åªãèžçºãããããã«å ç±ã¬ãã«ãäžããããšãå¿
èŠãšãªãã
段éïœïŒãã段éïœïŒããäŸãã°ïŒïŒåéã®éæµæéãå«ãããšããŸãæçã§ãããéæµã¯ã溶åªäžã§ã¯ã«ã¯ãã³ã溶解ããéçšäžããã³ç¶ããŠãªã³è質ã溶液ã«æ·»å ããåŸã«èµ·ããåŸãããããã®æ®µéäžããšã¿ããŒã«ã¯ã沞隰ããŠé€å»ããããããäžæ¹ã§å§å容åšäžã«ã¯äŸç¶ãšããŠå«æãããèžçºãããšã¿ããŒã«ãããã®éäžã埪ç°æ¹åŒã§åã³æº¶æ¶²ã«æ»ãããã«ãªãããã®éæµã¯è€åäœã®åœ¢æã«æçšã§ããã
補é æ¹æ³ã®ç¹ã«å¥œãŸããå®æœåœ¢æ
ã«ãããŠãæ¬æ¹æ³ã¯ã
ïœïŒç¬¬äžã®æº¶æ¶²ãçæãããããã«ããšã¿ããŒã«äžã§ããéã®ã¯ã«ã¯ãã³ã溶解ããïŒ
ïœïŒç¬¬äºã®æº¶æ¶²ãçæãããããã«ããªã³è質ãå«æããããéã®æµ·ç£ç©æ²¹ãšç¬¬äžã®æº¶æ¶²ãæ··åãïŒ
ïœïŒãªã³è質ãšã¯ã«ã¯ãã³ãšã®éã®è€åäœãåŸãããã«ã第äºã®æº¶æ¶²ãããšã¿ããŒã«ã沞隰é€å»ããã
段éãå«ãã
ïœïŒç¬¬äžã®æº¶æ¶²ãçæãããããã«ããšã¿ããŒã«äžã§ããéã®ã¯ã«ã¯ãã³ã溶解ããïŒ
ïœïŒç¬¬äºã®æº¶æ¶²ãçæãããããã«ããªã³è質ãå«æããããéã®æµ·ç£ç©æ²¹ãšç¬¬äžã®æº¶æ¶²ãæ··åãïŒ
ïœïŒãªã³è質ãšã¯ã«ã¯ãã³ãšã®éã®è€åäœãåŸãããã«ã第äºã®æº¶æ¶²ãããšã¿ããŒã«ã沞隰é€å»ããã
段éãå«ãã
ããã€ãã®å®æœåœ¢æ
ã«ãããŠãã¯ã«ã¯ãã³ããšã¿ããŒã«ããã³ãæµ·ç£ç©æ²¹ç±æ¥ã®ãªã³è質ãäžç·ã«åããããã®ç¬¬äºã®æº¶æ¶²ã圢æãããããã«æ··åããããšã«ãã£ãŠã段éïœïŒããã³ïœïŒãåæã«è¡ãã
ãããªã奜ãŸããå®æœåœ¢æ
ãšããŠã段éïœïŒã¯ãããéã®ã¬ã·ãã³ã第äžã®æº¶æ¶²ã«æ·»å ããããšãå«ãããã®å®æœåœ¢æ
ã«ãããŠãã¬ã·ãã³ãšæµ·ç£ç©æ²¹ãšã®æã奜ãŸããæ¯ã¯ãããïŒïŒïŒã§ããã
ãããªã奜ãŸããå®æœåœ¢æ
ãšããŠã段éïœïŒã¯ãããéã®åžéå€ã第äžã®æº¶æ¶²ã«æ·»å ããããšãå«ããåœç¶ã§ã¯ããããã¬ã·ãã³ããã³ïŒãŸãã¯åžéå€ã®æ·»å ã¯ãç°ãªã段éã§æ·»å ããåŸãæ¬çºæã®çµæãžã®é¡èãªåœ±é¿ã¯ãªãã
ããã€ãã®å¥œãŸããå®æœåœ¢æ
ã«ãããŠã沞隰ããã段éã倧æ°å§ä»¥äžã§è¡ãåŸãããã«ãã£ãŠããšã¿ããŒã«ã®æ²žç¹ãäžåãããã«ãããªã溶液ãå ç±ãããã
奜ãŸããå®æœåœ¢æ
ã«ãããŠãèžçºåšãéããŠã沞隰é€å»ããããšã¿ããŒã«ãéããååããã
ããã€ãã®å¥œãŸããå®æœåœ¢æ
ã«ãããŠããããªã溶液ãå«æãã容åšäžã®å§åãäœäžãããããšã«ãã£ãŠæ²žéš°ããã段éãè¡ãåŸãå§åäœäžã«ãã£ãŠãšã¿ããŒã«ã®æå¹æ²žç¹ãäœäžããã
ç空ã«ããããšã«ãã£ãŠèžçºã®æž©åºŠãäœäžãããããšã¯ãæ²¹ãå€æããæ©äŒãæžå°ãããã®ã§æå©ã§ãããæ²¹ã¯ãç±ãå
ããã³é
žçŽ ãžã®æé²ã«æåæ§ããããç空ã®äœ¿çšã«ãã£ãŠãæ²¹ã®å€æ§ã«å¯Ÿããç±ã®ããã³é
žçŽ ã®å¯äžã®äž¡æ¹ãæžå°ããã
奜ãŸããã¯ã段éïœïŒã¯ãïŒããïŒæéã«ãããïŒïŒããïŒïŒâååŸã§ã¹ããŒç空ïŒïœïœïœïœ ïœïœïœïœïœïœïŒãé©çšãã次ãã§å
šãšã¿ããŒã«ã沞隰é€å»ããããŸã§å®å
šç空ã«ããããšãå«ãã
ããã€ãã®å®æœåœ¢æ
ã«ãããŠããšã¿ããŒã«ãèžçºãããŠé€å»ããããã«ãå§åäœäžããã³ãããªã溶液ã®å ç±ã®çµã¿åãããå©çšãåŸãã
ç空ã«ããããšã«ããèžçºæž©åºŠãäœäžãããããšã¯ãæ²¹ãå€æããæ©äŒãæžå°ãããã®ã§æå©ã§ãããæ²¹ã¯ãç±ãå
ããã³é
žçŽ ãžã®æé²ã«æåæ§ããããç空ã®äœ¿çšã«ãã£ãŠãæ²¹ã®å€æ§ã«å¯Ÿããç±ã®ããã³é
žçŽ ã®å¯äžã®äž¡æ¹ãæžå°ããã
ããã€ãã®å®æœåœ¢æ
ã«ãããŠãå§åãäžæããåŸãããã«ãããšã¿ããŒã«ã®æ²žç¹ãäžæããããã«ãããšã¿ããŒã«ãèžçºãããããã«å ç±åºŠãé«ãããããšãå¿
èŠã«ãªãã
åœç¶ã®ããšãªããããããªã溶液ãå«æãããå§å容åšå
ã®å§åãå¢æžããããšã«ãã£ãŠèžçºé床ã調ç¯ãåŸãã
奜ãŸããå®æœåœ¢æ
ã«ãããŠãå§å容åšäžã®ç空å§åã¯ïŒããïŒïŒïœïœïœïœã®ç¯å²ã§ããã
æ¬çºæã®é·æïŒ
âæµ·ç£ç©æ²¹ãªã³è質ãšã¯ã«ã¯ãã³ãè€åäœåããããšã«ãã£ãŠãã¯ã«ã¯ãã³ãè€åäœã«ããä¿è·ãããã®ã§ãã€ãªã¢ãã€ã©ããªãã£ãæ¹åãããã
âãªã³è質ãšè€åäœåããããšã«ãã£ãŠãæ²¹ãšçµã¿åãããŠã¯ã«ã¯ãã³ãåçŽã«æ·»å ãããïŒè€åäœåããªãïŒå Žåã«èŠãããåé¢ãé²ãã
âæµ·ç£ç©æ²¹ãããªã³è質ãåŸãããšã«ãã£ãŠãè€åäœäžã®ã¯ã«ã¯ãã³ãšè質ãšã®å¥œãŸããã¢ã«æ¯ãéæã§ããããã«ãªãã
âæµ·ç£ç©æ²¹ç±æ¥ãªã³è質ãçšããããšã«ãã£ãŠãã¯ã«ã¯ãã³ãšã®ãªã¡ã¬ïŒèèªé žã®éã§èŠãããçžä¹çå¹æãæçã«ç¶æãããããªã¡ã¬ïŒèèªé žã¯æµ·ç£ç©æ²¹ãªã³è質äžã«ååšããã
âæ²»ççµæç©äžã§äœ¿çšãããæµ·ç£ç©æ²¹ãåºãäžè¬ããå容ãããä¿¡é Œæ§ãè¯å¥œã§ããã
âæµ·ç£ç©æ²¹ç±æ¥ãªã³è質ã®äžéšã®ä»£ããã«ã¬ã·ãã³ãæ·»å ããããšã«ãã£ãŠãæçã«ãæµ·ç£ç©æ²¹ç±æ¥ãªã³è質ã®èèªé žã«èµ·å ããã察å¿ããç²æ§äžæãªããã¯ã«ã¯ãã³ãšèèªé žãšã®ã¢ã«æ¯ãç¹å®ã®å¥œãŸããæ¯ïŒäŸãã°ãïŒïŒïŒïŒïŒ 察ã¯ã«ã¯ãã³ïŒã«äžæãããããšãã§ããããã«ãªããããã¯ãè€åäœäžã®ã¯ã«ã¯ãã³æ¿åºŠãçŽïŒïŒ ïœïŒïœããäžã«äžæãããããã«ç¹ã«æçã§ããåŸãã«ãã»ã«ã«åŠæ¹ããããšãäŸç¶ãšããŠå¯èœã§ããã
âæµ·ç£ç©æ²¹ããã³ïŒãŸãã¯ã¬ã·ãã³ã®äœããã®äžéšã®ä»£ããã«ãããªãåžéå€ãæ·»å ããããšã¯ãåŠæ¹è ãïŒïŒ ãäžåãã¬ã·ãã³æ¿åºŠãããã«äžæããããŸãã«ãã»ã«åæ³ã«å¯ŸããŠäœ¿çšå¯èœãªç²æ§ãäŸç¶ãšããŠç¶æããããšã«åœ¹ç«ã¡åŸãã
âæ¬çºæã¯ãŸããçŽïŒïŒïŒ ã¯ã«ã¯ãã³ãŸã§æ¿åºŠãåäžãããããšã«ãã£ãŠãå®å®ãªè€åäœã®æäŸããã³ã¯ã«ã¯ãã³ãšèèªé žãšã®ããé«ãã¢ã«æ¯ãããããããããããã®ãããªå®æœåœ¢æ ã«ãããŠãæã奜ãŸããéžæè¢ã¯ãçµæç©ã®ç²æ§ãããé«ããããé å€åããããšã§ããã
âæµ·ç£ç©æ²¹ãªã³è質ãšã¯ã«ã¯ãã³ãè€åäœåããããšã«ãã£ãŠãã¯ã«ã¯ãã³ãè€åäœã«ããä¿è·ãããã®ã§ãã€ãªã¢ãã€ã©ããªãã£ãæ¹åãããã
âãªã³è質ãšè€åäœåããããšã«ãã£ãŠãæ²¹ãšçµã¿åãããŠã¯ã«ã¯ãã³ãåçŽã«æ·»å ãããïŒè€åäœåããªãïŒå Žåã«èŠãããåé¢ãé²ãã
âæµ·ç£ç©æ²¹ãããªã³è質ãåŸãããšã«ãã£ãŠãè€åäœäžã®ã¯ã«ã¯ãã³ãšè質ãšã®å¥œãŸããã¢ã«æ¯ãéæã§ããããã«ãªãã
âæµ·ç£ç©æ²¹ç±æ¥ãªã³è質ãçšããããšã«ãã£ãŠãã¯ã«ã¯ãã³ãšã®ãªã¡ã¬ïŒèèªé žã®éã§èŠãããçžä¹çå¹æãæçã«ç¶æãããããªã¡ã¬ïŒèèªé žã¯æµ·ç£ç©æ²¹ãªã³è質äžã«ååšããã
âæ²»ççµæç©äžã§äœ¿çšãããæµ·ç£ç©æ²¹ãåºãäžè¬ããå容ãããä¿¡é Œæ§ãè¯å¥œã§ããã
âæµ·ç£ç©æ²¹ç±æ¥ãªã³è質ã®äžéšã®ä»£ããã«ã¬ã·ãã³ãæ·»å ããããšã«ãã£ãŠãæçã«ãæµ·ç£ç©æ²¹ç±æ¥ãªã³è質ã®èèªé žã«èµ·å ããã察å¿ããç²æ§äžæãªããã¯ã«ã¯ãã³ãšèèªé žãšã®ã¢ã«æ¯ãç¹å®ã®å¥œãŸããæ¯ïŒäŸãã°ãïŒïŒïŒïŒïŒ 察ã¯ã«ã¯ãã³ïŒã«äžæãããããšãã§ããããã«ãªããããã¯ãè€åäœäžã®ã¯ã«ã¯ãã³æ¿åºŠãçŽïŒïŒ ïœïŒïœããäžã«äžæãããããã«ç¹ã«æçã§ããåŸãã«ãã»ã«ã«åŠæ¹ããããšãäŸç¶ãšããŠå¯èœã§ããã
âæµ·ç£ç©æ²¹ããã³ïŒãŸãã¯ã¬ã·ãã³ã®äœããã®äžéšã®ä»£ããã«ãããªãåžéå€ãæ·»å ããããšã¯ãåŠæ¹è ãïŒïŒ ãäžåãã¬ã·ãã³æ¿åºŠãããã«äžæããããŸãã«ãã»ã«åæ³ã«å¯ŸããŠäœ¿çšå¯èœãªç²æ§ãäŸç¶ãšããŠç¶æããããšã«åœ¹ç«ã¡åŸãã
âæ¬çºæã¯ãŸããçŽïŒïŒïŒ ã¯ã«ã¯ãã³ãŸã§æ¿åºŠãåäžãããããšã«ãã£ãŠãå®å®ãªè€åäœã®æäŸããã³ã¯ã«ã¯ãã³ãšèèªé žãšã®ããé«ãã¢ã«æ¯ãããããããããããã®ãããªå®æœåœ¢æ ã«ãããŠãæã奜ãŸããéžæè¢ã¯ãçµæç©ã®ç²æ§ãããé«ããããé å€åããããšã§ããã
æ¬çºæã®ãããªãæ
æ§ã¯ãåã«äŸãšããŠäžãã次ã®èšèŒãããããã³æ·»ä»ã®å³é¢ãåç
§ããŠãæããã«ãªãã
å³ïŒã¯ãæ¬çºæã«ããç¹ã«å¥œãŸããçµæç©ãäœè£œããå
šäœçãªæ®µéã説æããæµãå³ã§ãããå³ïŒã®ããã¯ã¹ïŒã¯ãæ§ã
ãªæåãäŸãã°ã¯ã«ã¯ãã³ããšã¿ããŒã«ãæµ·ç£ç©æ²¹ããã³ã¬ã·ãã³ãªã©ãåããã段éã瀺ããåœç¶ã®ããšãªãããæ¬çºæã®ç¯å²ããéžè±ããããšãªãäœããã®é åºã§çµã¿åãããããšãè¡ãåŸãã
å³ïŒã®ããã¯ã¹ïŒã¯ãæ§ã
ãªæåãåäžã«ååžãããããã«ãããªã溶液ãæ··åãããæ··å段éã瀺ããåœç¶ã®ããšãªããããã®æ®µéã¯ãããã¯ã¹ïŒã®åããã段éããã³ïŒãŸãã¯æ®µéïŒã®éæµïŒèžçºãšçµã¿åããããåŸããåäžãªæ··åã確å®ã«ããããã«éæµïŒèžçºæ®µéïŒã®åã«äžå®æéã«ãããæ··å段éïŒãè¡ãåŸãã
å³ïŒã®ããã¯ã¹ïŒã¯éæµïŒèžçºæ®µéã瀺ãã次ã®ãã®ãå«ãå€ãã®æ¹æ³ã§éæµïŒèžçºãéæãåŸãïŒ
ã»æº¶åªãèžçºããŠé€å»ããããŸã§ãæ··åãããããªã溶液ãåšå²å§åã§æ²žéš°ãããããšïŒ
ã»æ··åãããããªã溶液ããé«æž©ãåšå²å§åãäžåãå§åã§æ²žéš°ãããããšïŒ
ã»æ··åãããããªã溶液ããäœæž©ãåšå²å§åãäžåãå§åã§æ²žéš°ãããããšã
ã»æº¶åªãèžçºããŠé€å»ããããŸã§ãæ··åãããããªã溶液ãåšå²å§åã§æ²žéš°ãããããšïŒ
ã»æ··åãããããªã溶液ããé«æž©ãåšå²å§åãäžåãå§åã§æ²žéš°ãããããšïŒ
ã»æ··åãããããªã溶液ããäœæž©ãåšå²å§åãäžåãå§åã§æ²žéš°ãããããšã
åœç¶ã®ããšãªããããããªã溶液ã®æ²žéš°ã¯ããããªãæµäœäžã«å«æãããïŒä»¥äžã®æµäœã®æ²žéš°ãå«ã¿åŸããäŸãã°ããã®ãããªæž©åºŠïŒå§åã溶åªã®ã¿ã沞隰é€å»ãããããã«èª¿ç¯ãåŸãã®ã§ã溶åªã®æ²žç¹ã¯ããããªãæµäœäžã®ä»ã®æµäœãããå®è³ªçã«äœããã®ã§ããåŸãã
èžçºé床ã調ç¯ããããã«ãæåã§ãŸãã¯èª¿ç¯ç³»ã«ãããã®äœããã§èžçºæ®µéã調ç¯ãåŸãã
å³ïŒã¯ãäžèšæ¹æ³ã®ãã詳现ãªæµãå³ã瀺ãã
äžè¬çã«ã¯ã䜿çšããããšããã¯ã«ã¯ãã³ã¯æåã«ç²æ«ã§ãããç²æ«ã溶åªäžã§æº¶è§£ãåŸãåŸããã溶液ãå°ãªããšãïŒä»¥äžã®ãããªãååç©ã«æ·»å ãåŸããïŒä»¥äžã®ãããªãååç©ãç²æ«åååç©ãå«ãå Žåãä»ã®ååç©ãšåãããåã«æº¶åªäžã§ãããã溶解ããåŸããç²æ§ã®ããæµäœãããæ»ããã«ããããã溶åªãç¹ã«ç²æ§ã®ããæµäœãšãåããåŸãã
ããã€ãã®å®æœåœ¢æ
ã«ãããŠãå°ãªããšã第äžã®æ§æèŠçŽ ãšå°ãªããšãïŒã€ã®ãããªãæ§æèŠçŽ ã®ãã¡å°ãªããšãïŒã€ãšã®éã®çµå床ã確èªããããã«ãéæµïŒèžçºæ®µéäžã«æµäœã®è©Šæãæ¡åããè©Šæãé å¿ããããšãå«ãããããªã段éãå«ãŸãåŸããåœç¶ã®ããšãªãããçµåãèµ·ãããªãã£ãå Žåãé å¿ã®çµæã圢æãã第äžã®æ§æèŠçŽ ã®æ²æ®¿ãèµ·ããã匷ãçµåãèµ·ãã£ãå Žåã¯ãé å¿äžã«æ²æ®¿ã¯ã»ãŒåœ¢æãããªãã
ïŒå®æœäŸïŒ
次ã®å®æœäŸãåç §ããããšã«ãã£ãŠæ¬çºæãããã«èšèŒãããããããããã®å®æœäŸã¯ãéå®ãããã®ãšè§£éããŠã¯ãªããªãã
次ã®å®æœäŸãåç §ããããšã«ãã£ãŠæ¬çºæãããã«èšèŒãããããããããã®å®æœäŸã¯ãéå®ãããã®ãšè§£éããŠã¯ãªããªãã
ïŒå®æœäŸïŒïŒè£œé æ¹æ³
ãã®å®æœäŸã«ãããŠãæ·»å ãããåæåã®éã¯ãå®æœäŸïŒã§èª¬æãããããã«ãééã«ãããéã«åºã¥ãã
段éïŒïŒç空ã¿ã³ã¯ã«ãããŠãïŒïŒããïŒïŒéšã®ãšã¿ããŒã«ãããéã®ã¯ã«ã¯ãã³ãã±ã«ã»ãã³ããã³ãããªã³ãšæ··åããã
段éïŒïŒæ··åã¯ãå šæåã溶解ããããŸã§ãéæµäžã§ããããïŒïŒããïŒïŒâã®æž©åºŠã§è¡ãã
段éïŒïŒããéã®ã€ã¬ã€æ²¹ããã³ã¬ã·ãã³ãæåã«äžç·ã«äºæ··åãã次ãã§æ®µéïŒã«ããçæããã溶液ã«æ·»å ããã
段éïŒïŒéæµïŒïŒååŸãã¹ããŒç空ïŒïœïœïœïœ ïœïœïœïœïœïœïŒäžã§ãïŒïŒããïŒïŒâååŸã§ïŒããïŒæéã次ãã§å šãšã¿ããŒã«ã沞隰é€å»ãããèžçºåšäžã§ååããããŸã§å®å šç空äžã§ã段éïŒããã®æ··åç©ãããã«æ··åããããã¯ã«ã¯ãã³ã¯è€åäœãšããŠãªã³è質ã«çµåãããŸãŸãšãªãã
ãã®å®æœäŸã«ãããŠãæ·»å ãããåæåã®éã¯ãå®æœäŸïŒã§èª¬æãããããã«ãééã«ãããéã«åºã¥ãã
段éïŒïŒç空ã¿ã³ã¯ã«ãããŠãïŒïŒããïŒïŒéšã®ãšã¿ããŒã«ãããéã®ã¯ã«ã¯ãã³ãã±ã«ã»ãã³ããã³ãããªã³ãšæ··åããã
段éïŒïŒæ··åã¯ãå šæåã溶解ããããŸã§ãéæµäžã§ããããïŒïŒããïŒïŒâã®æž©åºŠã§è¡ãã
段éïŒïŒããéã®ã€ã¬ã€æ²¹ããã³ã¬ã·ãã³ãæåã«äžç·ã«äºæ··åãã次ãã§æ®µéïŒã«ããçæããã溶液ã«æ·»å ããã
段éïŒïŒéæµïŒïŒååŸãã¹ããŒç空ïŒïœïœïœïœ ïœïœïœïœïœïœïŒäžã§ãïŒïŒããïŒïŒâååŸã§ïŒããïŒæéã次ãã§å šãšã¿ããŒã«ã沞隰é€å»ãããèžçºåšäžã§ååããããŸã§å®å šç空äžã§ã段éïŒããã®æ··åç©ãããã«æ··åããããã¯ã«ã¯ãã³ã¯è€åäœãšããŠãªã³è質ã«çµåãããŸãŸãšãªãã
ïŒå®æœäŸïŒïŒ
å®å®æ§ã«ãããã¯ã«ã¯ãã³âãªã³è質è€åäœã圢æããããšã®æå¹æ§ã説æããããã«ã次ã®å®éšãè¡ã£ãã
å®å®æ§ã«ãããã¯ã«ã¯ãã³âãªã³è質è€åäœã圢æããããšã®æå¹æ§ã説æããããã«ã次ã®å®éšãè¡ã£ãã
ãã¬ã³ããŒãçšããŠïŒééïŒ
ã¯ã«ã¯ãã³ç²æ«ãïŒïŒïŒïœïŒ¬ã®ã€ã¬ã€æ²¹ãšçŽæ¥æ··åããããšã«ãã£ãŠã察ç
§çµæç©ãäœè£œããããã¬ã³ããŒäžã§æ··åç©ãïŒïŒåéæ¿ããæ··åããã
次ã«ãå®æœäŸïŒïŒè£œé æ¹æ³ïŒããã³å®æœäŸïŒïŒå®æœäŸçµæç©ïŒã§æŠèª¬ããæ¹æ³ã«åŸããããã³æ¬çºæã«åŸããæ¯èŒå®éšçµæç©ïŒïŒïŒ
ã¯ã«ã¯ãã³ïŒãäœè£œããã
察ç
§ããã³å®éšçµæç©ã®äž¡æ¹ã ïŒïŒïŒïŒé å¿æ©ã«å
¥ããïŒïŒïŒïŒïŒïŒ§ã«ïŒæéãäŸããã察ç
§æ··åç©ã®ããããã«ã€ããŠãåŸãããæ²æ®¿ç©ã®ééã枬å®ããã
ãã®çµæããã察ç
§çµæç©ãå¯æº¶æ§ã¯ã«ã¯ãã³ãšããŠå
ãïŒïŒïŒééïŒ
ãæããããšã瀺ããããããã¯ãïŒïŒïŒããïŒïŒïŒïŒ
ïœïŒïœã®éã®ã¯ã«ã¯ãã³ã®å¯æº¶åã®æ¢ç¥ã®æ¯ãšçžé¢ãããéã«ãå®éšçµæç©ã¯æ²æ®¿ç©ãå
šãçããããããã®ããšãããïŒïŒ
ïœïŒïœã¯ã«ã¯ãã³å
šãŠãã€ã¬ã€æ²¹ãŸãã¯ã¬ã·ãã³ç±æ¥ã®äœããã®ãªã³è質ã«çµåããŠããããšã瀺ãããã
ïŒå®æœäŸïŒïŒ
çºæè ãã¯ãæµ·ç£ç©æ²¹ããã³ã¬ã·ãã³ã®äž¡æ¹ãæããçµæç©ãšãæµ·ç£ç©æ²¹ã®ã¿ãæããçµæç©ãæ¯èŒãããã¯ã«ã¯ãã³ã®æ¿åºŠã¯äž¡çµæç©ã«å¯ŸããŠïŒïŒ ïœïŒïœã«ç¶æããããã¬ã·ãã³ãæããçµæç©ã«ãããŠè€åäœã®å®å®æ§ã«ã¯åœ±é¿ããªãã£ãããšãåãã£ããããã¯ãã¯ã«ã¯ãã³è² è·éãïŒïŒ ïœïŒïœè¶ ã«å¢éããå Žåã§ããã¬ã·ãã³å«æçµæç©ã«å¯ŸããŠã奜éœåãªã«ãã»ã«åæè¡ãäŸç¶ãšããŠéæããåŸãããšãæå³ããã
çºæè ãã¯ãæµ·ç£ç©æ²¹ããã³ã¬ã·ãã³ã®äž¡æ¹ãæããçµæç©ãšãæµ·ç£ç©æ²¹ã®ã¿ãæããçµæç©ãæ¯èŒãããã¯ã«ã¯ãã³ã®æ¿åºŠã¯äž¡çµæç©ã«å¯ŸããŠïŒïŒ ïœïŒïœã«ç¶æããããã¬ã·ãã³ãæããçµæç©ã«ãããŠè€åäœã®å®å®æ§ã«ã¯åœ±é¿ããªãã£ãããšãåãã£ããããã¯ãã¯ã«ã¯ãã³è² è·éãïŒïŒ ïœïŒïœè¶ ã«å¢éããå Žåã§ããã¬ã·ãã³å«æçµæç©ã«å¯ŸããŠã奜éœåãªã«ãã»ã«åæè¡ãäŸç¶ãšããŠéæããåŸãããšãæå³ããã
æ¬çºæã®æ
æ§ã¯åãªãäŸãšããŠèšèŒããããã®ã§ãããåœç¶ã®ããšãªãããæ¬çºæã®ç¯å²ããéžè±ããããšãªããããã«å¯ŸããŠæ¹å€ããã³ä»å ããªããåŸãã
Claims (12)
- ãªã³è質ããã³ã¯ã«ã¯ãã³ãå«ãè€åäœã§ãã£ãŠãåèšãªã³è質ã®äžéšãŸãã¯å šãŠãæµ·ç£ãªã³è質ã§ããããšãç¹åŸŽãšãããè€åäœã
- åèšãªã³è質ãããã³ïŒãŸãã¯ïŒ¥ïŒ°ïŒ¡ãå«ããè«æ±é ïŒã«èšèŒã®è€åäœã
- åèšè€åäœäžã®åèšãªã³è質ã®å°ãªããšãäžéšããã¹ãã¡ããžã«ã³ãªã³ãå«ããè«æ±é ïŒããïŒã®äœããïŒé ã«èšèŒã®è€åäœã
- è€åäœäžã®ãªã³è質ã®ããéããã¬ã·ãã³ããäŸçµŠããããè«æ±é ïŒããïŒã®äœããïŒé ã«èšèŒã®è€åäœã
- ãããªã³ããã³ïŒãŸãã¯ã±ã«ã»ãã³ãå«ããè«æ±é ïŒããïŒã®äœããïŒé ã«èšèŒã®è€åäœã
- è«æ±é ïŒããïŒã®äœããïŒé ã«èšèŒã®è€åäœãå«ããçµæç©ã
- æµ·ç£ç©æ²¹ãå«ããè«æ±é ïŒã«èšèŒã®çµæç©ã
- åèšæµ·ç£ç©æ²¹ããïŒïŒïŒ ïœïŒïœãè¶ ãããªã³è質ãå«æãããè«æ±é ïŒã«èšèŒã®çµæç©ã
- ããªäžé£œåèèªé žïŒ€ïŒšïŒ¡ããã³ïŒãŸãã¯ïŒ¥ïŒ°ïŒ¡ã®ãããªãäŸçµŠæºãå«ããè«æ±é ïŒããïŒã®äœããïŒé ã«èšèŒã®çµæç©ã
- ã¢ãžã¥ãã³ããå«ããè«æ±é ïŒããïŒã®äœããïŒé ã«èšèŒã®çµæç©ã
- ã±ã«ã»ãã³ããã³ïŒãŸãã¯ãããªã³ãå«ããè«æ±é ïŒããïŒïŒã®äœããïŒé ã«èšèŒã®çµæç©ã
- è«æ±é ïŒããïŒã®äœããïŒé ã«èšèŒã®è€åäœã調補ããæ¹æ³ã§ãã£ãŠã
ïœïŒç¬¬äžã®æº¶æ¶²ãçæãããããã«ã溶åªäžã§ããéã®ã¯ã«ã¯ãã³ã溶解ããïŒ
ïœïŒç¬¬äºã®æº¶æ¶²ãçæãããããã«ãããéã®æµ·ç£ãªã³è質ãšåèšç¬¬äžã®æº¶æ¶²ãæ··åãïŒ
ïœïŒåèšè€åäœãçæãããããã«ãåèšç¬¬äºã®æº¶æ¶²ãåŠçãïŒ
ïœïŒåèšæº¶åªããåèšè€åäœãåé¢ããã
段éãå«ããæ¹æ³ã
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ60014612 | 2012-05-22 | ||
NZ600146 | 2012-05-22 | ||
PCT/NZ2013/000086 WO2013176555A1 (en) | 2012-05-22 | 2013-05-22 | Improved complexes and compositions containing curcumin |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2015518862A JP2015518862A (ja) | 2015-07-06 |
JP2015518862A5 true JP2015518862A5 (ja) | 2016-01-14 |
JP6211603B2 JP6211603B2 (ja) | 2017-10-11 |
Family
ID=49624145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015513962A Expired - Fee Related JP6211603B2 (ja) | 2012-05-22 | 2013-05-22 | ã¯ã«ã¯ãã³ãå«æããæ¹åãããè€åäœããã³çµæç© |
Country Status (10)
Country | Link |
---|---|
US (1) | US20150104503A1 (ja) |
EP (2) | EP3666265A1 (ja) |
JP (1) | JP6211603B2 (ja) |
KR (2) | KR20150035730A (ja) |
CN (3) | CN111407752A (ja) |
AU (1) | AU2013264466B2 (ja) |
CA (1) | CA2910089A1 (ja) |
HK (1) | HK1208375A1 (ja) |
IN (1) | IN2014MN02552A (ja) |
WO (1) | WO2013176555A1 (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102013220974A1 (de) * | 2013-10-16 | 2015-04-16 | Briu Gmbh | Zusammensetzung zur oralen Administration von Curcumin |
JP6987528B2 (ja) * | 2017-05-12 | 2022-01-05 | å°æ補è¬æ ªåŒäŒç€Ÿ | ã¯ã«ã¯ããã€ãå«æé å€ |
CN109589410B (zh) * | 2018-12-26 | 2022-02-01 | æšå çç©ç§æéå¢è¡ä»œæéå ¬åž | äžç§å§é»çŽ å¶ååå ¶å¶å€æ¹æ³ |
CN109846865B (zh) * | 2018-12-26 | 2022-03-25 | æšå çç©ç§æéå¢è¡ä»œæéå ¬åž | äžç§å§é»çŽ å¶ååå ¶å¶å€æ¹æ³ |
KR102169710B1 (ko) * | 2020-01-08 | 2020-10-26 | ì 죌ëíêµ ì°ííë ¥ëš | 컀í믌 ëë žì€íŒìŽ, ê·ž ì ì¡°ë°©ë² ë° ìŽì ì©ë |
WO2022052017A1 (en) * | 2020-09-11 | 2022-03-17 | Liu Hsuan Miao | Pharmaceutical compositions and uses thereof in treating muscle atrophy |
WO2023119230A1 (en) | 2021-12-22 | 2023-06-29 | L'oreal | Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use |
WO2023161955A1 (en) * | 2022-02-28 | 2023-08-31 | Gidaa Life Sciences Pvt. Ltd. | A phytoactive encapsulated formulation for neurodegenerative diseases |
CN115813780A (zh) * | 2022-03-30 | 2023-03-21 | 广äžæ Œç¯çç©ç§æè¡ä»œæéå ¬åž | äžç§å«åæ°¢å§é»çŽ ç纳米级ç¥é»ç»åç©åå ¶å¶å€æ¹æ³ |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1201149B (it) * | 1987-01-14 | 1989-01-27 | Indena Spa | Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche |
CA2606255C (fr) | 2005-04-18 | 2013-10-08 | Sc Dicophar | Utilisation de la lecithine comme medicament dans le traitement du psoriasis |
WO2007098118A2 (en) * | 2006-02-16 | 2007-08-30 | Byron Robinson Pharmaceutical, Inc. | Antineoplastic and curcumin derivatives and methods of preparation and use |
EP1993365B1 (en) * | 2006-03-06 | 2013-05-08 | The Regents of the University of California | Bioavailable curcuminoid formulations for treating alzheimer's disease and other age-related disorders |
EP1837030A1 (en) * | 2006-03-09 | 2007-09-26 | INDENA S.p.A. | Phospholipid complexes of curcumin having improved bioavailability |
CN102988373A (zh) * | 2006-07-19 | 2013-03-27 | 執å èšæ¯å€§åŠ***è£äºäŒ | çšäºæ²»ççæ§è ç ç磷èäžå«æ5-æ°šåºæ°Žæšé žä¹è¯ç©çå¶å€ç© |
IT1395086B1 (it) * | 2009-03-11 | 2012-09-05 | Velleja Res Srl | Composizioni comprendenti curcumina in forma complessata con fosfolipidi e piperina ad azione chemio-sensibilizzante |
-
2013
- 2013-05-22 CN CN202010235467.XA patent/CN111407752A/zh active Pending
- 2013-05-22 US US14/402,071 patent/US20150104503A1/en not_active Abandoned
- 2013-05-22 WO PCT/NZ2013/000086 patent/WO2013176555A1/en active Application Filing
- 2013-05-22 CN CN201380038818.6A patent/CN104540515A/zh active Pending
- 2013-05-22 EP EP20150592.2A patent/EP3666265A1/en not_active Withdrawn
- 2013-05-22 CA CA2910089A patent/CA2910089A1/en not_active Abandoned
- 2013-05-22 KR KR20147036049A patent/KR20150035730A/ko active Application Filing
- 2013-05-22 CN CN201911125449.XA patent/CN110870857A/zh active Pending
- 2013-05-22 EP EP13793432.9A patent/EP2852395A4/en not_active Withdrawn
- 2013-05-22 AU AU2013264466A patent/AU2013264466B2/en active Active
- 2013-05-22 JP JP2015513962A patent/JP6211603B2/ja not_active Expired - Fee Related
- 2013-05-22 KR KR1020197021718A patent/KR20190090075A/ko not_active Application Discontinuation
-
2014
- 2014-12-16 IN IN2552MUN2014 patent/IN2014MN02552A/en unknown
-
2015
- 2015-09-18 HK HK15109169.9A patent/HK1208375A1/xx unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6211603B2 (ja) | ã¯ã«ã¯ãã³ãå«æããæ¹åãããè€åäœããã³çµæç© | |
JP2015518862A5 (ja) | ||
US20070122452A1 (en) | Fat composition | |
US20150110866A1 (en) | Complexes and compositions containing curcumin | |
JP2007504197A (ja) | ãã¹ãã¡ããžã«ã»ãªã³å¡©åºã®ççåŠç掻æ§çµæç© | |
WO2015121378A1 (en) | Liquid phospholipid-containing compositions for the preparation of pharmaceuticals | |
US10960016B2 (en) | Capsules containing high doses of krill phospholipids | |
JP4913340B2 (ja) | ã«ãã»ã«å€ | |
EP3206677A1 (en) | Monounsaturated fatty acid compositions and use for treating atherosclerosis | |
NZ610906A (en) | Improved complexes and compositions containing curcumin | |
JP4969989B2 (ja) | ãªã³è質çµæç©ããã³ãããå«æããé£åçµæç©ãå»è¬åçµæç©ã䞊ã³ã«ãã®è£œé æ¹æ³ | |
JP6949670B2 (ja) | é£æº¶æ§ç©è³ªãå«æããçµå£æåçšçµæç©ãé£æº¶æ§ç©è³ªã®æ¶å管åžåæ§ã®åäžæ¹æ³åã³é£æº¶æ§ç©è³ªãå«æããæ°Žäžæ²¹åä¹³åç©ã®èå ã§ã®ä¹³åå®å®åæ¹æ³ | |
NZ610906B (en) | Improved complexes and compositions containing curcumin | |
WO2015185238A1 (en) | Homogeneous formulation comprising omega-3 polyunsatured fatty acid and resveratrol for oral administration | |
JP5221114B2 (ja) | ãœããã«ãã»ã«å€ | |
TW200904456A (en) | Organic compounds | |
WO2023275190A1 (en) | Soft gel capsule | |
WO2011124895A2 (en) | Phospholipid-containing pharmaceutical and nutraceutical compositions | |
US20200022941A1 (en) | Long-term efficacy of liver disease treatment with EPA and DHA | |
EP3057578A1 (de) | Zusammensetzung zur oralen administration von curcumin | |
JP2001288079A (ja) | ç¹ç°ç殺ç现èå€åã³ãããé åããŠãªãçµæç© | |
JP2012051945A (ja) | ã«ãã»ã«å€ãã«ãã»ã«å€ã®è£œé æ¹æ³ããã³ã«ãã»ã«ç®è |